Introduction {#s1}
============

Most excitatory synapses are formed on dendritic spines---small protrusions that decorate the shaft of neuronal dendrites ([@bib13]; [@bib30]). Changes in the size and shape of individual spines are closely associated with Long-term potentiation (LTP), a cellular correlate of learning and memory ([@bib22]; [@bib74]; [@bib42]; [@bib12]; [@bib47]). Moreover, abnormal spine morphology and/or density are hallmarks of Intellectual Disability and other cognitive dysfunctions, including Autism-Spectrum Disorders and schizophrenia ([@bib21]; [@bib54]). These findings suggest that precise regulation of dendritic spine morphology and number is critical for normal cognition.

Spines are highly enriched in actin filaments, and dynamic modulation of the actin cytoskeleton is crucial for controlling not only spine formation and elimination, but also modifications of the size, shape and motility of existing spines ([@bib30]; [@bib12]). In response to local synaptic cues, neurons can rapidly alter the morphology of individual spines ([@bib42]; [@bib51]; [@bib29]; [@bib46]). This process likely requires precise spatial regulation of proteins that increase actin polymerization and those that sever/disassemble actin filaments in a given spine. However, many actin regulators are predicted to be soluble, diffusible proteins, which appear poorly suited to operate with the necessary spatial specificity. This raises the question of how spatially precise, spine-specific actin regulation is achieved.

We hypothesized that neurons must possess mechanisms to localize and/or confine certain actin regulatory proteins within dendritic spines, not only to ensure spine-specific regulation but perhaps also to control actin polymerization/depolymerization at the subspine level. One mechanism to control protein localization is palmitoylation, a protein-lipid modification that targets cytosolic proteins to specific membranes ([@bib25]; [@bib67]). Palmitoylation occurs in all eukaryotic cells but appears to be especially important in neurons because human genetic mutations and mouse knockouts of Palmitoyl acyltransferases (PATs, which catalyze palmitoylation) frequently lead to neurological and/or cognitive deficits ([@bib25]; [@bib26]). We therefore hypothesized that palmitoylation might modulate actin regulators to ensure spatially restricted signaling in spines.

Two important actin regulatory proteins are the LIM kinases (LIMK1 and LIMK2 \[[@bib63]\]), which phosphorylate and inactivate the actin severing protein cofilin, thus promoting actin polymerization ([@bib45]; [@bib3]; [@bib72]). Interestingly, LIMK1 appears particularly important for actin regulation in spines, because *LIMK1* knockout in mice or genetic mutation in humans is associated with spine abnormalities and cognitive impairments ([@bib23]; [@bib65]; [@bib43]). Moreover, although LIMK1\'s upstream activator in neurons is unclear, spine abnormalities and intellectual impairments are also linked to mutations in *PAK3* ([@bib1]; [@bib10]), a member of the p21-activated kinase (PAK) family that phosphorylates and activates LIMK1 in non-neuronal cells ([@bib19]). These findings link PAK/LIMK1-dependent regulation of actin polymerization to the control of spine morphology and higher brain function. However, PAKs and LIMKs are predicted soluble, cytosolic proteins. How, then, might they regulate actin with the necessary spatial precision?

Here we report that palmitoylation of LIMK1 at a specific N-terminal motif is necessary and sufficient to target LIMK1 to spines. Palmitoyl-LIMK1 is essential for normal spine actin turnover, activity-dependent morphological plasticity and long-term spine stability. Strikingly, palmitoylation controls not only LIMK1 localization but also its activation by PAK in neurons. This novel 'dual-control' mechanism ensures spatially precise actin regulation at the single spine and potentially also the subspine levels.

Results {#s2}
=======

A conserved palmitoyl-motif in LIMK1 {#s2-1}
------------------------------------

To address whether palmitoylation of actin regulators facilitates spatial control of actin polymerization in spines, we performed two bioinformatic searches for potential palmitoyl-motifs in actin regulatory proteins. LIMK1 was a prominent hit in both searches and adjacent cysteine residues (Cys7, Cys8, conserved in all vertebrate LIMK1 orthologs) were predicted to be palmitoylated ([Figure 1A](#fig1){ref-type="fig"}).10.7554/eLife.06327.003Figure 1.Palmitoylation at a unique di-cysteine motif targets LIMK1 to dendritic spines.(**A**). *Upper panel*: LIMK1 schematic, showing predicted palmitoyl-motif (CC, red) and LIM, PDZ and kinase domains. *Lower panel*: Multiple sequence alignment of the N-terminal region of LIMK1 orthologs from the indicated species. CC palmitoylation motif (highlighted with asterisks) is conserved in vertebrates. (**B**) HEK293T cells were transfected with C-terminal myc-tagged LIMK1wt (wt-LIMK1-myc) or CCSS-LIMK1-myc (cys 7, 8 mutated to Ser). ABE fractions prepared from lysates were blotted to detect palmitoyl-LIMK1 (top panel). Lysates were blotted to detect total LIMK1 expression (bottom panel). CCSS mutation eliminates LIMK1 palmitoylation. (**C**) LIMK1 palmitoylation increases, coincident with spine maturation and synapse formation. Hippocampal neurons, cultured for the indicated number of Days in vitro (DIV), were lysed and identical amounts of total protein were subjected to ABE to detect palmitoyl-LIMK1. (**D**) Homogenate and palmitoylated (ABE) fractions from rat forebrain were blotted to detect LIMK1. (**E**) Palmitoylation targets LIMK1 to dendritic spines. Representative images of hippocampal neurons (DIV18), transfected to express GFP plus Wt-LIMK1-myc or CCSS-LIMK1-myc and immunostained with the indicated antibodies. Scale bar: 20 μm. Lower panels show magnified images of single dendrites (scale bar: 1 μm). (**F**) Quantified spine targeting ratio (signal intensity in dendritic spines compared to adjacent dendritic shaft) for each construct from **E**. Data are mean + SEM for n = 30 neurons for each condition. \*p \< 0.05, ANOVA with Dunnett\'s *post hoc* correction.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.003](10.7554/eLife.06327.003)10.7554/eLife.06327.004Figure 1---figure supplement 1.Palmitoylation helps to anchor LIMK1 in spines.(**A**) Hippocampal neurons (DIV18) were transfected with the indicated GFP-tagged LIMK1 cDNAs plus morphology marker (mCherry). 18--24 hr post-transfection, a ROI centered on an individual spine (yellow circle) was photobleached (third column) and fluorescence recovery was monitored (right column). (**B**) Quantified FRAP from n = 12--18 spines per condition from **A**. (**C**) Histogram of the stable fraction of wt- and CCSS-LIMK1-GFP, calculated as in 'Materials and methods'. \*p \< 0.05, t-test. (**D**) Histogram of the half-time of recovery of the dynamic fraction of mobile LIMK1-GFP, determined by fitting individual fluorescence recovery traces to a single exponential. \* p \< 0.05, t-test. Although this result is statistically significant, note that the determination for wt-LIMK1-GFP is affected by the very low fraction of recovery seen in many individual traces, which reduces the accuracy of curve-fitting. Recovery half-times for wt- and CCSS-LIMK1-GFP are markedly longer than other proteins that are predicted to be freely soluble in spines ([@bib62]; [@bib8]; [@bib76]).**DOI:** [http://dx.doi.org/10.7554/eLife.06327.004](10.7554/eLife.06327.004)10.7554/eLife.06327.005Figure 1---figure supplement 2.Further evidence that palmitoylation targets LIMK1 to spines.(**A**) Treatment of hippocampal neurons with the palmitoylation inhibitor 2-Bromopalmitate (2-Br) confirms palmitoylation of LIMK1. Cultured hippocampal neurons (DIV20) were treated with 2-Br (100 µM) or vehicle control (EtOH) for the indicated times. ABE assays were performed to detect palmitoylated and total LIMK1 levels. (**B**) Representative images of DIV18 hippocampal neurons, transfected to express GFP plus wt-LIMK1-myc, treated with 100 mM 2-Br or vehicle 2 hr post-transfection, fixed 12 hr later and immunostained with the indicated antibodies. Scale bar: 20 μm. Lower panels show magnified images of single dendrites (scale bar: 1 μm). (**C**) Spine targeting ratio (mean ± SEM) for n = 32 neurons per condition from **B**. \* p \< 0.05, ANOVA with Dunnett\'s *post hoc* correction. (**D**) Quantified assessment of dendritic morphology for each condition in **B** confirms that 2-Br treatment does not affect dendritic spine density, n = 20--30 neurons per condition, p \> 0.05, ANOVA with Dunnett\'s *post hoc* correction.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.005](10.7554/eLife.06327.005)

To test whether the LIMK1 Cys7/Cys8 (CC) motif is indeed palmitoylated, we transfected HEK293T cells with C-terminal myc-tagged wild type LIMK1 (wt-LIMK1-myc) or CCSS-LIMK1-myc (Cys7/Cys8 mutated to non-palmitoylatable Ser). To isolate palmitoyl-proteins, we subjected lysates to Acyl-biotin exchange (ABE). ABE uses an exchange of thioester-linked acyl modifications (i.e., palmitoylation), for biotin, with the resultant biotinylated proteins being affinity-purified using neutravidin-conjugated beads ([@bib69]; [@bib66]). Wt-LIMK1-myc was clearly detected in ABE fractions, indicative of palmitoylation, but was not detected in control purifications in which the essential ABE reagent hydroxylamine (NH~2~OH) was omitted ([Figure 1B](#fig1){ref-type="fig"}). In contrast, CCSS-LIMK1-myc was not detected in ABE fractions ([Figure 1B](#fig1){ref-type="fig"}), suggesting that LIMK1 is palmitoylated at Cys7/Cys8.

Palmitoylation is necessary to target and confine LIMK1 to dendritic spines {#s2-2}
---------------------------------------------------------------------------

To investigate the neuronal role of palmitoyl-LIMK1, we examined LIMK1 palmitoylation in cultured hippocampal neurons, focusing on four developmental stages: 4 days in vitro (DIV4), when neurites are extending; DIV8, when dendrites elaborate and undergo branching; DIV12, when dendritic spines first appear and DIV20, when spines and synapses are mature (a time course similar to previous reports \[[@bib33]; [@bib6]\]). Interestingly, despite similar LIMK1 protein expression across these developmental stages, palmitoyl-LIMK1 was not detected in ABE fractions from DIV4 neurons ([Figure 1C](#fig1){ref-type="fig"}). However, palmitoyl-LIMK1 became detectable at DIV8, increased markedly at DIV12 and remained prominent at DIV20 ([Figure 1C](#fig1){ref-type="fig"}). These findings suggest that LIMK1 is palmitoylated in hippocampal neurons and that its palmitoylation coincides with spine development and maturation. This conclusion is consistent with the robust palmitoylation of LIMK1 in adult rat forebrain homogenates ([Figure 1D](#fig1){ref-type="fig"}).

The temporal correlation of LIMK1 palmitoylation and spine formation ([Figure 1C](#fig1){ref-type="fig"}), and the altered spine morphology in *LIMK1* knockout mice ([@bib43]), suggested that palmitoyl-LIMK1 might play a specific role in spines. In support of this hypothesis, wt-LIMK1 was highly enriched in spines but CCSS-LIMK1 was not ([Figure 1E,F](#fig1){ref-type="fig"}). We reasoned that palmitoylation might anchor LIMK1 in spines to limit its diffusion, thus enhancing spatial control of actin regulation. We therefore transfected neurons with GFP-tagged LIMK1 and monitored its diffusibility by Fluorescence Recovery After Photobleaching (FRAP) using time-lapse imaging. Prominent FRAP, indicative of diffusion of the tagged protein, was observed with CCSS-LIMK1-GFP but not with wt-LIMK1-GFP ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Quantitative analysis of FRAP data confirmed that CCSS mutation decreased the stable fraction of LIMK1-GFP in spines ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We note that the time course of LIMK1-GFP FRAP, irrespective of its palmitoylation status, is markedly slower than previously characterized soluble proteins ([@bib62]; [@bib8]; [@bib76]). This suggests that other factors, most likely protein--protein interactions, are important to constrain LIMK1 in spines. However, our FRAP results suggest that palmitoylation, in addition to targeting LIMK1 to spines, also increases the fraction of LIMK1 that is stably anchored in spine heads.

As an additional line of evidence that the impaired spine targeting caused by Cys7,8 mutation is palmitoylation-specific, we used a pharmacological approach. The palmitoylation inhibitor 2-Bromopalmitate (2-Br; \[[@bib32]\]) did not affect endogenous LIMK1 protein levels, but greatly reduced LIMK1 palmitoylation in neurons ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}), reinforcing the conclusion that LIMK1 is palmitoylated. In parallel experiments, 2-Br greatly reduced wt-LIMK1 spine targeting without affecting overall spine numbers ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The similar effects of CCSS mutation and 2-Br treatment strongly suggest that Cys7/Cys8 palmitoylation is required for LIMK1 spine targeting.

LIMK1\'s dual palmitoylation motif is sufficient for spine targeting {#s2-3}
--------------------------------------------------------------------

We next asked whether LIMK1\'s palmitoylation motif is sufficient for spine targeting. LIMK1-GFP deletion mutants lacking the kinase domain (LIMK1-1-258) or lacking the kinase and PDZ domains (LIMK1 1-137) localized to spines as effectively as full-length LIMK1 ([Figure 2A--C](#fig2){ref-type="fig"}). Remarkably, a minimal palmitoylation motif construct lacking the kinase, PDZ and LIM domains (LIMK1 \[1--15\]-GFP; [Figure 2A--C](#fig2){ref-type="fig"}) was sufficient to target GFP to spines. In contrast, cytosolic GFP was not enriched in spines ([Figure 2A--C](#fig2){ref-type="fig"}). These findings indicate that LIMK1\'s N-terminal 15 amino acid sequence is a specific spine targeting motif.10.7554/eLife.06327.006Figure 2.LIMK1\'s palmitoyl-motif is a minimal spine targeting sequence.(**A**) Schematic of LIMK1 deletion mutants. (**B**) LIMK1\'s palmitoyl-motif is sufficient for spine targeting. Representative images of hippopcampal neurons (DIV18), transfected to express mCherry plus the indicated GFP-tagged LIMK1 deletion mutants from **A** and immunostained with the indicated antibodies (scale bar: 20 μm). Lower panels show magnified images of single dendrites (scale bar: 1 μm). (**C**) Spine targeting ratio (mean ± SEM ) for n = 5--15 neurons per condition from **B**. n.s.; p \> 0.05 compared to wt-LIMK1-GFP. \*; p \< 0.05 compared to GFP. ANOVA with Tukey *post hoc* test.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.006](10.7554/eLife.06327.006)10.7554/eLife.06327.007Figure 2---figure supplement 1.Dual palmitoylation is necessary for LIMK1 spine targeting.(**A**) Schematic of LIMK1 single palmitoylation site mutants (SC-LIMK1, CS-LIMK1) and a LIMK1 mutant in which a sequence directing addition of the lipid myristate is added to the N-terminus of CCSS-LIMK1 (Myr-CCSS-LIMK1). (**B**) Representative images of hippocampal neurons (DIV18), transfected to express the indicated myc-tagged LIMK1 constructs from **A**, plus GFP (morphology marker), immunostained with the indicated antibodies. Scale bar: 20 μm. Lower panels show magnified images of dendrites (scale bar: 1 μm). (**C**) Quantified spine targeting ratio for n = 30 neurons per condition from **B** confirm that only wt-LIMK1-myc is enriched in spines. \*:p \< 0.05, ANOVA with Dunnett\'s *post hoc* correction. (**D**) Confocal images of cell soma regions from the same conditions as in **B** show apparent enrichment of SC-LIMK1 and CS-LIMK1 on intracellular membranes, raising the possibility that the remaining cysteine is palmitoylated in these mutants.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.007](10.7554/eLife.06327.007)10.7554/eLife.06327.008Figure 2---figure supplement 2.LIMK1 mutants that are predicted to be dually lipid modified are not enriched in spines.(**A**) Schematic of LIMK1 mutants that are predicted to be dually lipid modified with myristate plus palmitate (Myr-SC-LIMK1, Myr-CS-LIMK1). (**B**) Representative images of hippocampal neurons (DIV18), transfected to express the indicated myc-tagged LIMK1 constructs from **A**, plus GFP (morphology marker), immunostained with the indicated antibodies. Scale bar: 20 μm. Lower panels show magnified images of dendrites (scale bar: 1 μm). (**C**) Quantified spine targeting ratio for n = 6 neurons per condition from **B** confirm that only wt-LIMK1-myc is enriched in spines. \*:p \< 0.05, ANOVA with Dunnett\'s *post hoc* correction.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.008](10.7554/eLife.06327.008)

Other post-synaptic palmitoyl-proteins contain di-cysteine motifs ([@bib34]; [@bib25]; [@bib14]), raising the possibility that LIMK1 must be dually palmitoylated to localize to spines. Consistent with this notion, C7S- and C8S-LIMK1 mutants were not targeted to spines ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Moreover, a CCSS-LIMK1 mutant carrying a sequence that directs addition of the lipid myristate (Myr-CCSS-LIMK1), which can mimic a single palmitoylation event ([@bib66]), was not targeted to spines ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

Lastly, we examined the spine targeting of N-terminal mutants of LIMK1 that are predicted to be doubly lipid-modified with myristate plus single palmitate (Myr-SC-LIMK1, Myr-CS-LIMK1). Neither of these mutants was enriched in spines ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Taken together, these results suggest that an intact CC palmitoyl-motif is critical for spine LIMK1 targeting.

LIMK1\'s palmitoyl-motif accounts for differential localization of LIMK1 and LIMK2 {#s2-4}
----------------------------------------------------------------------------------

Interestingly, *LIMK1* genetic loss or mutation affects spine structure and cognition, despite the presence of LIMK2, which is also expressed in hippocampal neurons ([@bib17]). However, we hypothesized that LIMK2\'s lacks of a CC palmitoyl-motif ([Figure 3A](#fig3){ref-type="fig"}) might render LIMK2 unable to localize to spines and thus unable to compensate for loss of LIMK1. Consistent with this notion, LIMK1 was detected in rat brain Post-Synaptic Density (PSD) fractions, including the PSDIII fraction, which is enriched in spine-associated proteins. In contrast, LIMK2 was absent from PSD fractions ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) and was not enriched in spines ([Figure 3C,D](#fig3){ref-type="fig"}). Biochemical and immunocytochemical assays thus suggest that LIMK1 is targeted to spines but LIMK2 is not. Strikingly, however, a chimeric protein consisting of LIMK1\'s minimal spine targeting sequence fused to LIMK2 was readily detected in spines ([Figure 3C,D](#fig3){ref-type="fig"}). This result suggests that LIMK1\'s palmitoyl-motif accounts for differential localization of the two LIMKs, potentially explaining why loss of LIMK1 causes spine-specific phenotypes.10.7554/eLife.06327.009Figure 3.LIMK1\'s palmitoyl-motif accounts for differential localization of LIMK1 and LIMK2.(**A**) Schematic of LIMK1 (top) and LIMK2 (middle), showing similar overall domain arrangement. Rat LIMK1 and LIMK2 kinase domains are 70% identical, 84% similar (NCBI BLAST). Expanded N-terminal sequences show LIMK1\'s unique CC motif. Lower schematic shows a chimeric protein in which the N-terminal 15 amino acids of LIMK1 are fused to LIMK2 ('Chimera LIMK2'). (**B**) The indicated rat forebrain subcellular fractions were blotted to detect endogenous LIMK1 and LIMK2. LIMK1 is seen in Post-synaptic Density (PSD) fractions, consistent with a previous study, but LIMK2 is not. Fidelity of the preparation and antibody specificity is confirmed in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. (**C**) Hippocampal neurons (DIV18) were transfected to express GFP plus the indicated myc-tagged LIMK variants. Representative images of single neurons immunostained with the indicated antibodies are shown (scale bar: 20 μm). Lower panels show magnified images of single dendrites. (**D**) Spine targeting ratio (mean ± SEM) for n = 30 neurons per condition from **C**. \* p \< 0.05; n.s.: p \> 0.05, ANOVA with Dunnett\'s *post hoc correction*.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.009](10.7554/eLife.06327.009)10.7554/eLife.06327.010Figure 3---figure supplement 1.Specificity of LIMK1 and LIMK2 antibodies and fidelity of subcellular fractionation.(**A**) HEK293T cells were transfected with empty vector, wtLIMK1-myc or wtLIMK2-myc. Lysates were blotted with the indicated antibodies. (**B**) Blotting of rat brain subcellular fractions with presynaptic marker (synaptophysin) and postsynaptic marker (PSD-95) confirms the fidelity of the preparation from [Figure 3B](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.010](10.7554/eLife.06327.010)

Loss of palmitoyl-LIMK1 impacts spine actin turnover {#s2-5}
----------------------------------------------------

The striking effects of palmitoylation on LIMK1 targeting to, and anchoring in, dendritic spines ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) suggested that palmitoylation is critical for LIMK1-dependent control of actin polymerization ([@bib3]; [@bib72]) in spines. To examine this possibility, while circumventing possible issues arising from LIMK1\'s neurodevelopmental roles ([@bib43]; [@bib58]), we used small hairpin RNA (shRNA) knockdown/rescue to replace endogenous LIMK1 with the CCSS-LIMK1 mutant in mature neurons. We first identified an shRNA that potently reduced levels of cotransfected rat LIMK1-myc ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The same shRNA greatly reduced endogenous LIMK1 levels when packaged into lentiviral particles and used to infect hippocampal neurons ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). [sh]{.ul}RNA-[r]{.ul}esistant (shr) 'rescue' forms of wt-LIMK1 (shr-wt-LIMK1-myc) and CCSS-LIMK1 (shr-CCSS-LIMK1-myc) were insensitive to LIMK1 shRNA ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

To address palmitoyl-LIMK1\'s role in spine actin regulation, we used FRAP to monitor the dynamics of GFP-tagged beta actin (GFP-actin) in single spines ([@bib62]; [@bib51]; [@bib31]). Actin filaments in spines normally turn over rapidly, due to treadmilling, while actin monomers exchange bidirectionally between spines and the adjacent dendritic shaft (\[[@bib62]; [@bib12]\]; [Figure 4A](#fig4){ref-type="fig"}). If GFP-actin in a spine is photobleached, new fluorescent GFP-actin monomers normally diffuse into the spine and are incorporated into the barbed end of bleached filaments, predominantly in the juxtamembrane ('shell') region of the spine head ([@bib31]; [@bib24]). Concomitantly, bleached actin molecules are severed from filament pointed ends (closer to the spine 'core') and exchange out of the spine, which recovers its fluorescence. However, if turnover is impaired, bleached GFP-actin remains trapped within filaments and FRAP is attenuated. The fraction of actin filaments in the spine that are undergoing rapid turnover can thus be determined from the extent of FRAP ([@bib62]).10.7554/eLife.06327.011Figure 4.Acute loss of palmitoyl-LIMK1 impairs Fluorescence Recovery After Photobleaching (FRAP) of GFP-actin in dendritic spines.(**A**) Schematic of FRAP assay. GFP-actin is photobleached in a single spine. When actin filament turnover is normal, fluorescence recovers as new fluorescent actin molecules are incorporated at the barbed ends of filaments, while bleached actin is released from pointed ends. (**B**) Hippocampal neurons (DIV17) were transfected to coexpress GFP-actin and mCherry with or without LIMK1 shRNA, plus shr-LIMK1 rescue constructs as indicated. Dual color live images of individual dendrites are shown for each condition. (**C**) Images of baseline GFP-actin signal from the same dendritic regions shown in **B** (left column, t = 0 s, Pre-bleach). A Region of Interest (ROI, yellow circle) was photobleached and the dendrite was imaged immediately thereafter (second column images, 'Bleach') and at the indicated times post-bleach (third, fourth columns). (**D**) FRAP curves (normalized to average pre-bleach fluorescence), plotted from multiple single-spine ROIs for each condition from **C**. Values are mean ± SEM, n = 16--26 spines per condition. (**E**) Histogram of the stable fraction of GFP-actin (mean ± SEM) between t = 250 s and t = 300 s, calculated for each individual FRAP trace used to generate the pooled data in **D**. (Control vector: 8.3 ± 2.8%; LIMK1 knockdown: 32.2 ± 3.6%; shr-wt-LIMK1 'rescue': 15.3 ± 2.4%; shr-CCSS-LIMK1 'rescue': 41.0 ± 4.0%. \*, p \< 0.05 compared to control vector, n.s.; not significantly different, ANOVA with Dunnett\'s *post hoc correction*.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.011](10.7554/eLife.06327.011)10.7554/eLife.06327.012Figure 4---figure supplement 1.Schematic and efficacy of shRNA knockdown/rescue approach.(**A**) Experimental design schematic. Transfected cells express mCherry (morphology marker) with or without LIMK1 shRNA. A cotransfected vector expresses shRNA-resistant (shr-) wt-LIMK1 or CCSS-LIMK1. (**B**) Effective shRNA knockdown/rescue of LIMK1. HEK293T cells were transfected with wt-LIMK1-myc, shr-wt-LIMK1-myc or shr-CCSS-LIMK1-myc cDNAs, plus either empty vector or LIMK1 shRNA-expressing vector. Lysates were blotted to detect LIMK1-myc (top) and tubulin (load control, bottom). Cotransfected LIMK1 shRNA suppresses expression of wt-LIMK1-myc (lanes 1, 2) but not shr-wt-LIMK1-myc (lanes 3, 4) or shr-CCSS-LIMK1-myc (lanes 5, 6). (**C**) Hippocampal neurons (DIV9) were infected with control or LIMK1 shRNA lentiviruses, generated using the vector in **A**. At DIV15, lysates were prepared and immunoblotted to detect LIMK1 and tubulin (load control). (**D**) Acute LIMK1 knockdown does not affect spine number. Hippocampal neurons were transfected with vector expressing morphology marker (GFP) with or without LIMK1 shRNA as in [Figure 5](#fig5){ref-type="fig"}, fixed 24 hr later and immunostained with anti-GFP antibody. Spines were outlined using Metamorph software and spine density per 10 micron length of dendrite was quantified.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.012](10.7554/eLife.06327.012)10.7554/eLife.06327.013Figure 4---figure supplement 2.Further analysis of FRAP data confirms that acute loss of palmitoyl-LIMK1 increases the pool of stable GFP-actin in dendritic spines.(**A**) Individual data points from FRAP experiments for each of the indicated conditions, which were used to generate the averaged traces shown in [Figure 4D](#fig4){ref-type="fig"}. (**B**) Histogram (mean ± SEM) of the stable fraction of GFP-actin (*F*~*s*~*/*\[*F*~*s*~ ± *F*~*d*~\], where *F*~*d*~ represents the dynamic pool) for each condition in [Figure 4](#fig4){ref-type="fig"}, calculated as in [@bib35] (see 'Materials and methods' for details). \*; p \< 0.05 compared to control vector, n.s.; not significantly different from control condition, ANOVA with Dunnett\'s *post hoc* correction. (**C**) Histogram of half-time of the dynamic component of GFP-actin, calculated by fitting individual traces to a single exponential (similar to [@bib62]; [@bib36]). (**D**) Table summarizing the indicated measurements from GFP-actin FRAP experiments, for the histograms in panel **B** (first column) and panel **C** (second column). The third column shows the recovery half-time of the dynamic component, calculated as in [@bib35]. Results using this method are very similar to those obtained by curve-fitting. \*; p \< 0.05 compared to control vector.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.013](10.7554/eLife.06327.013)

Live imaging of GFP-actin and cotransfected mCherry in DIV17 hippocampal neurons revealed numerous morphologically mature (stubby or mushroom-shaped) spines containing strong GFP-actin signals ([Figure 4B](#fig4){ref-type="fig"}). Selective photobleaching of single spines rapidly reduced GFP-actin fluorescence, which recovered to an extent similar to previous reports ([Figure 4C--E](#fig4){ref-type="fig"}; \[[@bib62]\]). LIMK1 'knockdown' neurons expressing GFP-actin, mCherry and LIMK1 shRNA had no change in spine number or morphology in the short term (24 hr post transfection; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). However, the recovery of GFP-actin fluorescence in LIMK1 knockdown neurons was significantly attenuated, compared to control neurons. This attenuated recovery was evident in plots of the averaged data ([Figure 4D](#fig4){ref-type="fig"}), or plots of all individual FRAP measurements ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) and is consistent with an increase in the percentage of stable GFP-actin. Two analytical methods confirmed that the fraction of stable actin is indeed significantly increased in LIMK1 knockdown spines ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), see also \[[@bib35]\]). Strikingly, the increase of stable GFP-actin caused by LIMK1 knockdown was restored to control levels by shr-wt-LIMK1, but not by shr-CCSS-LIMK1 ([Figure 4C--E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}).

In contrast to these marked effects on the pool of stable actin, the half-time of GFP-actin fluorescence recovery was not significantly different under any condition examined ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Taken together, these data suggest that the predominant effect of loss of palmitoyl-LIMK1 on GFP-actin turnover is to reduce the pool of mobile actin in spines. This deficit is initially surprising, because LIMK1 is best known as a negative regulator of cofilin, and increased cofilin activity in the absence of palmitoyl-LIMK1 might be expected to *increase* actin turnover. We consider possible molecular explanations for this finding in the 'Discussion', but taken together, these results suggest that palmitoyl-LIMK1 is essential for normal actin turnover in spines.

Palmitoyl-LIMK1 is critical for activity-dependent spine enlargement {#s2-6}
--------------------------------------------------------------------

We next sought to identify functional consequences of impaired spine actin turnover, caused by loss of palmitoyl-LIMK1. Spine morphological plasticity critically requires actin polymerization ([@bib42]; [@bib51]), and could thus potentially also require palmitoyl-LIMK1. To address this possibility, we used shRNA knockdown/rescue in organotypic hippocampal slices and examined spine-specific morphological plasticity following focal activation of glutamate receptors by 2-photon (2P) uncaging of MNI-glutamate ([@bib42]; [@bib28]).

In biolistically transfected CA1 pyramidal neurons expressing the morphology marker mCherry, focal uncaging of MNI-glutamate on spines induced a rapid, lasting volume increase of the stimulated spine, similar to published results (135 ± 7% of initial volume, 15--25 min post-uncaging; [Figure 5A,B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). An analogous uncaging protocol (i.e., pairing to 0 mV in whole-cell recordings) likewise led to a persistent increase in the volume of the stimulated spine that was accompanied by a spine-specific increase in the amplitude of uncaging-evoked postsynaptic currents (uEPSCs; [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).10.7554/eLife.06327.014Figure 5.Palmitoyl-LIMK1 is required for spine-specific activity-dependent morphological plasticity.(**A**) *Left panels*: images of individual neurons in organotypic hippocampal slices expressing mCherry with or without LIMK1 shRNA. Magnified images of individual dendrites were acquired at the indicated times prior to and following uncaging of MNI-Glutamate on the head of the indicated spine (white circles). Scale bars: low magnification, 20 μm, magnified, 2 μm. (**B**) Time course of normalized spine-head volume (mean ± SEM) of stimulated and neighboring spines (control: 24 stimulated spines, 72 neighbors, 6 neurons; LIMK1 shRNA: 28 stimulated spines, 84 neighbors, 6 neurons). Average normalized spine volume (15--25 min post-uncaging) was plotted and used for statistical comparison (\*: p \< 0.05, Mann--Whitney U test, details in main text). (**C**, **D**) Images and time courses plotted as in **A**, **B** for neurons expressing mCherry (Control; 21 stimulated spines, 63 neighbors, 6 neurons) or mCherry, LIMK1 shRNA and shr-wt-LIMK1-GFP (LIMK1-shRNA + WT rescue; 27 stimulated spines, 81 neighbors, 8 neurons). (**E**, **F**) Images and time courses plotted as in **A**, **B** for neurons expressing mCherry (control; 23 stimulated spines, 69 neighbors, 6 neurons) or mCherry, LIMK1 shRNA and shr-CCSS-LIMK1-GFP (LIMK1-shRNA+ CCSS rescue; 28 stimulated spines, 84 neighbors, 8 neurons).**DOI:** [http://dx.doi.org/10.7554/eLife.06327.014](10.7554/eLife.06327.014)10.7554/eLife.06327.015Figure 5---figure supplement 1.Probability of spine growth or shrinkage in response to glutamate uncaging.(**A**) *Upper left*: individual traces for the average data in [Figure 5A](#fig5){ref-type="fig"} for control (vector-transfected) neurons. Normalized volumes for each spine, color-coded based on whether spine volume increased (red), decreased (green), or did not change (black) post-uncaging. Pie chart summarizes percentage of spines in each category. *Lower left*: average normalized spine volume (15--25 min post-uncaging), plotted against initial spine diameters for each spine. *Right panels*: same as left panels but for spines from LIMK1 'knockdown' neurons. LIMK1 knockdown not only reduced the magnitude of activity-dependent spine enlargement ([Figure 6A](#fig6){ref-type="fig"}), but also decreased spine growth success (12/26 spines; 46%) compared with control neurons (18/24 spines; 75%). LIMK1 knockdown also more frequently caused spine shrinkage (5/26 spines; 19%) compared with control neurons (1/24 spines; 4%). (**B**) Individual traces for average data from [Figure 5C](#fig5){ref-type="fig"}, plotted as in **A** for spines from interleaved control and shRNA-LIMK1 + WT 'rescue' neurons. Spine growth success was similar in wt-LIMK1 rescue neurons (19/27 spines; 70%) and controls (15/21 spines; 71%). (**C**) Individual traces for the average data in [Figure 5E](#fig5){ref-type="fig"}, plotted as in **A** for spines from interleaved control and shRNA-LIMK1 + CCSS 'rescue' neurons. CCSS-LIMK1 'rescue' more frequently caused spine shrinkage (5/28 spines; 18%) compared with controls (1/23 spines; 4%).**DOI:** [http://dx.doi.org/10.7554/eLife.06327.015](10.7554/eLife.06327.015)10.7554/eLife.06327.016Figure 5---figure supplement 2.2-photon uncaging of MNI-glutamate induces spine-specific increases in both spine volume and synaptic strength.(**A**) A CA1 pyramidal neuron in an organotypic hippocampal slice is filled with Alexa594 dye via the patch pipette. Repetitive focal uncaging of MNI-glutamate (4 ms pulses at 720 nm, 30 pulses, 0.5 Hz) when neurons are clamped at 0 mV results in structural enlargement of stimulated spine but not unstimulated control spines (spine volume at 10--20 min post LTP; stimulated spines: 141.3 ± 7.4% of baseline, *n* = 11 spines, p \< 0.01; unstimulated spines: 106.4 ± 9.6% of baseline, *n* = 11 spines, p = 0.519 ). (**B**) Amplitude of uncaging-evoked excitatory postsynaptic currents (uEPSCs) from stimulated spines (at −70 mV) was also significantly increased following single spine repetitive uncaging at 0 mV (normalized uEPSC amplitude at 10--20 min post LTP; stimulated spines: 1.31 ± 0.13, *n* = 11 spines, p \< 0.05; unstimulated spines: 0.89 ± 5.5, *n* = 11 spines, p = 0.09).**DOI:** [http://dx.doi.org/10.7554/eLife.06327.016](10.7554/eLife.06327.016)

In subsequent experiments we focused on activity-dependent spine enlargement and first addressed the requirement for LIMK1 in this process. In CA1 pyramidal neurons expressing mCherry plus LIMK1 shRNA, activity-dependent spine enlargement was significantly attenuated (116 ± 6% of initial volume, 15--25 min post-uncaging; p = 0.032 vs control neurons, Mann--Whitney U test; [Figure 5A,B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This result suggests that LIMK1 is required for activity-dependent spine enlargement, consistent with the importance of actin polymerization in this process ([@bib42]; [@bib51]). Strikingly, activity-dependent spine enlargement could be rescued by shr-wt-LIMK1 (control: 136 ± 6%; wt-LIMK1 rescue: 140 ± 8%, p = 0.496, Mann--Whitney U test) but not by shr-CCSS-LIMK1 (interleaved control: 141 ± 10%; CCSS-LIMK1: 115 ± 4%, p = 0.031, Mann--Whitney U test; [Figure 5C--F](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). These findings suggest that palmitoyl-LIMK1 is required for activity-dependent spine enlargement.

Long term loss of palmitoyl-LIMK1 causes spine and synapse elimination {#s2-7}
----------------------------------------------------------------------

Acute loss of palmitoyl-LIMK1 markedly impaired spine actin turnover without affecting dendritic spine number ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). However, we hypothesized that chronically impaired actin turnover and activity-dependent plasticity caused by absence of palmitoyl-LIMK1 ([Figures 4, 5](#fig4 fig5){ref-type="fig"}), might detrimentally impact spine stability. To address this possibility, we transfected mature neurons to express GFP plus/minus LIMK1 shRNA and examined spine density 5 days later. This prolonged LIMK1 knockdown significantly reduced dendritic spine density, which was rescued by cotransfected shr-wt-LIMK1 but not by shr-CCSS-LIMK1 ([Figure 6A,B](#fig6){ref-type="fig"}). Absence of LIMK1 concomitantly reduced the number of excitatory synapses (defined as spines positive for pre- and postsynaptic markers; [Figure 6C,D](#fig6){ref-type="fig"}). Loss of both spines and synapses was rescued by shr-wt-LIMK1 but not shr-CCSS-LIMK1 ([Figure 6C,D](#fig6){ref-type="fig"}). Together, these results suggest that prolonged loss of palmitoyl-LIMK1 leads to spine instability and synapse loss.10.7554/eLife.06327.017Figure 6.Prolonged loss of palmitoyl-LIMK1 reduces dendritic spine and synapse number.(**A**) Hippocampal neurons (DIV17) transfected to express GFP alone (first panel), GFP plus LIMK1 shRNA (second panel), or GFP plus LIMK1 shRNA, plus the indicated LIMK1 'rescue' constructs (third, fourth panels). Neurons were fixed 5 days later and immunostained to detect GFP and myc. Scale bar: 20 μm. Lower panels show magnified images of single dendrites (scale bar: 1 μm). (**B**) Spine density per 10 μm dendritic length from multiple neurons from **A** (mean ± SEM: control vector: 5.38 ± 0.48 spines; LIMK1 shRNA: 3.23 ± 0.15 spines; shRNA plus shr-wt-LIMK1: 4.99 ± 0.41 spines; shRNA plus shr-CCSS-LIMK1: 3.82 ± 0.40 spines; \*p \< 0.05 compared to control vector, ANOVA, Dunnett\'s *post hoc correction*. N = 40--50 neurons per condition). (**C**) Neurons transfected as in **A** were immunostained to detect GFP (morphology marker, green), presynaptic marker synapsin I (blue) and postsynaptic marker PSD-95 (red) (scale bar, 1 μm). (**D**) Quantified density (mean ± SEM) of colocalized PSD-95 and synapsin I puncta (morphologically defined synapses) per 10 μm dendritic length per condition from **C**. (Synaptic puncta: vector alone: 6.83 ± 0.76; LIMK1 shRNA: 4.12 ± 0.21; shRNA plus shr-wt-LIMK1: 5.54 ± 0.32; shRNA plus shr-CCSS-LIMK1: 3.71 ± 0.28; \*p \< 0.05 compared to control vector, ANOVA with Dunnett\'s *post hoc correction*. N = 30 neurons per condition).**DOI:** [http://dx.doi.org/10.7554/eLife.06327.017](10.7554/eLife.06327.017)

Dual palmitoylation is critical for neuronal LIMK1 activation via a CaMKII/PAK-dependent pathway {#s2-8}
------------------------------------------------------------------------------------------------

The failure of CCSS-LIMK1 to rescue effects of LIMK1 knockdown to control spine actin turnover, morphological plasticity and spine stability ([Figures 4--6](#fig4 fig5 fig6){ref-type="fig"}) was striking because CCSS-LIMK1 is not absent from spines, only not enriched in spine heads ([Figure 1](#fig1){ref-type="fig"}). Indeed, despite robust expression, CCSS-LIMK1 is essentially a null mutant ([Figures 4--6](#fig4 fig5 fig6){ref-type="fig"}), suggesting that dual palmitoylation controls not only LIMK1 localization, but also LIMK1 function in neurons.

To test this hypothesis, we first addressed whether CCSS mutation affects LIMK1 function in vitro. In in vitro kinase assays, LIMK1\'s upstream activator PAK3 phosphorylated wt-LIMK1 and CCSS-LIMK1 with similar kinetics and to a similar extent (assessed by a phospho-specific antibody recognizing LIMK1\'s activation site (T508); [Figure 7A,B](#fig7){ref-type="fig"}). Moreover, following activation by PAK3, wt- and CCSS-LIMK1 phosphorylated their downstream substrate cofilin to a similar extent in vitro ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). These results suggest that CCSS mutation affects neither LIMK1\'s phosphorylation by PAK3, nor LIMK1\'s ability to phosphorylate cofilin. It is thus also unlikely that CCSS mutation grossly affects LIMK1 structure.10.7554/eLife.06327.018Figure 7.Di-palmitoylation is critical for LIMK1 activation in neurons.(**A**) CCSS mutation does not affect LIMK1 T508 phosphorylation in vitro. Wt- and CCSS-LIMK1-GFP were incubated in vitro with Mg-ATP, with or without active PAK3. Reactions were stopped at the indicated times, subjected to SDS-PAGE and immunoblotted to detect phospho-T508 LIMK1 and total LIMK1. (**B**) Quantified data (mean ± SEM, N = 3 determinations per condition) from assays in **A**. Timecourse and extent of phosphorylation of Wt- and CCSS-LIMK1 by PAK3 is similar in vitro. (**C**) Dual palmitoylation is uniquely required for LIMK1 T508 phosphorylation in neurons. Hippocampal neurons transfected with the indicated myc-tagged LIMK1 constructs were lysed and myc immunoprecipitates were immunoblotted to detect phospho-T508 and total LIMK1. (**D**) Quantified signals (mean ± SEM) for N = 3--6 determinations per condition from **C**. \*p \< 0.05 compared to wt-LIMK1-myc. ANOVA with Dunnett\'s *post hoc correction*. Note that phosphorylation of Myr-CS LIMK1 differs from that of CS-LIMK1 or Myr-CCSS-LIMK1 (ANOVA). This result suggests that, at least for Myr-CS-LIMK1, addition of the myristolyation tag does not interfere with recognition of the remaining palmitoyl-site.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.018](10.7554/eLife.06327.018)10.7554/eLife.06327.019Figure 7---Figure supplement 1.CCSS mutation does not affect phosphorylation of cofilin by LIMK1.Wt-LIMK1-GFP and CCSS-LIMK1-GFP were purified from transfected HEK293T cells and phosphorylated in vitro by PAK3 as in [Figure 7A](#fig7){ref-type="fig"}, then assayed for their ability to phosphorylate recombinant cofilin. Both wt- and CCSS-LIMK1 phosphorylate cofilin to a very similar extent.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.019](10.7554/eLife.06327.019)

In striking contrast, T508 phosphorylation of wt-LIMK1 in hippocampal neurons was approximately 10-fold higher than that of CCSS-LIMK1. SC-LIMK1, CS-LIMK1 and Myr-CCSS-LIMK1 mutants were also only weakly phosphorylated in neurons ([Figure 7C,D](#fig7){ref-type="fig"}). The doubly lipid-modified mutants, in particular Myr-CS-LIMK1, were phosphorylated to a slightly greater extent than CCSS-LIMK1, but still significantly less than wild type LIMK1 ([Figure 7C,D](#fig7){ref-type="fig"}). These results suggest that spine targeting (which is only achieved by dual palmitoylation), and not membrane association per se, is the key factor that controls LIMK1 phosphorylation and activation in neurons.

These findings suggest that a signaling pathway assembled on the spine membrane activates palmitoyl-LIMK1. However, despite links between LIMK1 and activity-dependent spine signaling ([@bib11]), the pathway that activates LIMK1 in spines is unclear. LIMK1 can be phosphorylated by either PAK or ROCK family kinases ([@bib19]; [@bib40]), both of which are active at the membrane because they bind active forms of Rac/Rho/Cdc42 small G proteins. Interestingly, PAK inhibition, but not ROCK inhibition, greatly reduced LIMK1 phosphorylation in hippocampal neurons ([Figure 8A,B](#fig8){ref-type="fig"}), suggesting that PAK is the key LIMK1 activator in spines. This conclusion is supported by the robust phosphorylation of LIMK1 by PAK3 in vitro ([Figure 7A](#fig7){ref-type="fig"}), and by prior links between PAKs and activity-dependent morphological plasticity of single spines ([@bib46]). Moreover, consistent with findings that spine morphological plasticity requires CaMKII ([@bib39]), a CaMKII inhibitor also greatly reduced LIMK1 phosphorylation ([Figure 8A,B](#fig8){ref-type="fig"}). Together, these findings suggest that CaMKII in spines triggers Rac/Cdc42 activation, which recruits active PAK to phosphorylate and activate wtLIMK1 specifically on the spine membrane.10.7554/eLife.06327.020Figure 8.Activation of palmitoyl-LIMK1 in neurons requires CaMKII and PAK, but not ROCK.(**A**) Hippocampal neurons transfected with the indicated cDNAs were left untreated, or were incubated for 1 hr with PAK inhibitor FRAX 486 (5 μM), ROCK inhibitor Y27632 (10 μM), or CaMKII inhibitor KN93 (10 μM) prior to lysis. Myc immunoprecip-itates were blotted with the indicated antibodies. (**B**) Quantified data of multiple determinations from **A** confirms that LIMK1 phosphorylation in neurons is PAK- and CaMKII-dependent, but not ROCK-dependent. (\*p \< 0.05 compared to control (no drug), ns: not significant. ANOVA with Dunnett\'s *post hoc correction*. n = 5--7 determinations per condition).**DOI:** [http://dx.doi.org/10.7554/eLife.06327.020](10.7554/eLife.06327.020)

Discussion {#s3}
==========

Palmitoylation of LIMK1 controls actin dynamics in dendritic spines {#s3-1}
-------------------------------------------------------------------

The importance of palmitoylation in neuronal regulation is increasingly appreciated, but most studies have focused on how this modification controls the localization of receptors and their 'scaffold' protein partners ([@bib25]; [@bib67]). This study reveals a novel role for palmitoylation in the spatial control of signaling events that regulate neuronal actin polymerization. It has been unclear how actin regulatory proteins, many of which are predicted to be diffusible, can control spatially precise changes in dendritic spine morphology. Our results suggest that one key factor in the spatial control of actin dynamics is palmitoylation of the actin regulator LIMK1, which is required for normal actin turnover in spines, for spine-specific structural plasticity and for long-term spine stability. These findings reveal new mechanisms that may govern both spine-specific morphological plasticity and perhaps also intra-spine control of actin dynamics.

How does palmitoylation regulate LIMK1 localization and signaling? {#s3-2}
------------------------------------------------------------------

The functional requirement for palmitoyl-LIMK1 in spine-specific regulation likely arises from at least three different effects of palmitoylation on LIMK1 at the cellular and molecular level. First, palmitoylation is critical for LIMK1 enrichment in dendritic spines ([Figure 1](#fig1){ref-type="fig"}). Interestingly, even LIMK1 mutants that are predicted to be dually lipidated (Myr-SC- and Myr-CS-LIMK1) are not spine-enriched, suggesting that dual palmitoylation is the key factor that controls LIMK1 spine targeting. Consistent with this notion, LIMK1\'s dual palmitoylation motif is sufficient to target a heterologous protein (GFP) to spines ([Figure 2](#fig2){ref-type="fig"}). It is remarkable that such specific targeting information is contained within such a short sequence. Moreover, to our knowledge, no other specific spine-targeting motif has been described. LIMK1\'s 1--15 sequence could hence be extremely useful to deliver any protein of interest specifically to spines, which could facilitate a range of studies into spine and synaptic biology.

Second, palmitoylation increases the stable fraction of LIMK1 in spines and thus helps to anchor LIMK1 in spine heads ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). However, although this effect is significant, even CCSS-LIMK1 fluorescence recovery is far slower than that reported for cytosolic GFP ([@bib62]; [@bib76]) and is also markedly slower than that of the proteasome subunit Rpt1, a protein of similar size to LIMK1 ([@bib8]). Other factors, most likely protein--protein interactions, are thus likely major determinants of LIMK1\'s limited diffusibility in spines, with palmitoylation exerting an additional stabilizing effect.

Third, dual palmitoylation is critical for LIMK1 phosphorylation at its activatory T508 site in neurons. In contrast, palmitoyl-site mutants (CCSS-LIMK1, SC-LIMK1 and CS-LIMK1), although not absent from spines, are not phosphorylated, and phosphorylation of myristoylated LIMK1 mutants (Myr-CCSS-LIMK1, Myr-SC-LIMK1, Myr-CS-LIMK1) is also very low. These results suggest that enrichment on the spine membrane, rather than membrane attachment per se, is essential for LIMK1 phosphorylation in neurons. A plausible reason for this spine-specific activation is that key LIMK1 activators, in particular active forms of CaMKII and PAK, are also specifically enriched on or adjacent to the spine membrane (\[[@bib59]; [@bib75]\], [Figure 9](#fig9){ref-type="fig"}).10.7554/eLife.06327.021Figure 9.Model of palmitoyl-LIMK1-dependent control of actin dynamics in dendritic spines.Dendritic spine schematic (left panel) with the indicated region expanded (blue boundary) to the right. Palmitoylation targets LIMK1 to the spine membrane, where it is phosphorylated by membrane-bound activators such as Rac/Cdc42/PAK. In contrast, any non-palmitoylated LIMK1 in the spine 'core' remains inactive. By governing both LIMK1 localization and activation, palmitoylation may also facilitate local, juxtamembrane-specific phosphorylation of cofilin and/or other LIMK1 substrates to enhance the spatial control of actin filament turnover in spines. For clarity, other actin regulatory processes such as filament capping and branching are not shown.**DOI:** [http://dx.doi.org/10.7554/eLife.06327.021](10.7554/eLife.06327.021)

Cdc42/Rac, PAK and palmitoyl-LIMK1 are critical for activity-dependent plasticity of single spines {#s3-3}
--------------------------------------------------------------------------------------------------

The palmitoylation-dependence of LIMK1 localization and activation sheds new light on mechanisms that spatially restrict signaling to selected spines. The small G proteins Cdc42 and Rac are critical for activity-dependent spine enlargement ([@bib46]), but their ability to ensure spatially precise actin regulation would appear limited if key 'downstream' effectors such as PAKs and LIMKs ([@bib19]; [@bib46]) were freely diffusible. However, because synaptic localization of LIMK1 is tightly regulated by palmitoylation ([Figure 1](#fig1){ref-type="fig"}), Rac/Cdc42/PAK/LIMK1 signals can remain spatially localized, ensuring spine-specific actin regulation ([Figure 9](#fig9){ref-type="fig"}).

Interestingly, molecular requirements for spine-specific morphological plasticity and changes in glutamate-evoked transmission (i.e., activity-dependent functional plasticity) are very similar, with both requiring both Cdc42 signaling and also actin polymerization ([@bib42]; [@bib46]). We found that very similar stimulation protocols trigger changes in spine volume that are palmitoyl-LIMK1-dependent ([Figure 5](#fig5){ref-type="fig"}) and also induce spine-specific functional plasticity ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). These findings raise the possibility that palmitoyl-LIMK1 is essential not only for structural but also functional plasticity, and may be a key link between the spine-specific Cdc42 signaling and actin polymerization described by others.

Downstream targets of palmitoyl-LIMK1 that control actin dynamics {#s3-4}
-----------------------------------------------------------------

Our study provides new insights into spatial control of the dendritic spine cytoskeleton, but what substrate(s) is responsible for palmitoyl-LIMK1-dependent effects on dendritic spine actin turnover ([Figure 4](#fig4){ref-type="fig"}) and activity-dependent spine enlargement ([Figure 5](#fig5){ref-type="fig"})? Multiple lines of evidence suggest a key role for cofilin, LIMK1\'s best known substrate, in these processes. Not only is cofilin phosphorylation critical for activity-dependent spine enlargement ([@bib27]), but elevated neuronal activity rapidly increases both spine volume ([Figure 5](#fig5){ref-type="fig"}; \[[@bib42]; [@bib73]\]) and also endogenous levels of phosphorylated, inactive cofilin ([@bib56]). However, despite these links, it is possible that additional and/or different palmitoyl-LIMK1 substrates contribute to the functional effects that we observe.

Even if cofilin is the key substrate via which palmitoyl-LIMK1 exerts effects on spines, some of our results are worthy of further discussion. One might predict that increases in dephospho- (active) cofilin, caused by LIMK1 knockdown, would lead to an excess of short actin filaments and/or actin monomers, so that GFP-actin fluorescence in our FRAP experiments would recover more rapidly and/or to a greater extent. Surprisingly, though, a significant percentage of actin in LIMK1 knockdown (and CCSS-LIMK1 'rescue') spines appears to be very stable. One possible explanation for this finding is that LIMK1 knockdown may increase the formation of cofilin-actin rods ([@bib4]), stable structures that are formed only by dephospho-cofilin ([@bib7]). However, while well documented within neurites, cofilin-actin rods have not been reported within spines.

A second explanation arises from the ability of active (dephospho-) cofilin to induce a twist in actin filament conformation that propagates along the filament ([@bib5]). Filaments are more likely to sever at boundaries between cofilin-bound (twisted) and unbound (untwisted) regions ([@bib9]). However, an entire cofilin-bound filament, as might occur in some LIMK1 knockdown (or CCSS-LIMK1 rescue) spines, is more stable than a bare filament ([@bib18]; [@bib2]). Thus, LIMK1 knockdown may lead to a subset of filaments that are decorated with active cofilin but which are actually more stable.

A third, intriguing explanation arises from findings that LTD-like stimuli (low frequency electrical stimulation or bath application of NMDA) markedly increase actin filament stability in spines ([@bib62]). Strikingly, our LTP-like glutamate uncaging stimulus results in shrinkage of a subset of spines (an LTD-like effect), almost exclusively restricted to the LIMK1 knockdown and CCSS-LIMK1 rescue conditions ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This suggests that some LIMK1 knockdown (and CCSS-LIMK1 rescue) spines respond to LTP-like inputs with LTD-like outputs that is, that their learning rules are impaired. LIMK1 knockdown and CCSS-LIMK1 'rescue' spines may therefore interpret spontaneous bursts of activity in cultured neurons as an LTD-like stimulus. In the short term this may result in decreased actin filament turnover, as previously reported ([@bib62]), while over longer times this impaired actin turnover may underlie the spine shrinkage and synapse loss seen in the absence of palmitoyl-LIMK1.

Finally, we cannot exclude the possibility that additional palmitoyl-LIMK1 substrate(s) rather than cofilin are responsible for effects on actin turnover and/or morphological plasticity. Super-resolution and/or electron microscopy approaches may provide more insight into how actin filament structure and/or turnover is altered in the absence of palmitoyl-LIMK1. However, while the molecular explanation remains to be elucidated, our results strongly suggest that palmitoylation of LIMK1 is critical for normal actin filament turnover in spines.

Could palmitoyl-LIMK1 control polarized 'shell-to-core' actin regulation in spines? {#s3-5}
-----------------------------------------------------------------------------------

If cofilin is indeed the key palmitoyl-LIMK1 substrate responsible for the functional effects that we observe then could this provide insight into the sub-spine control of actin dynamics? Previous studies reveal a directional flow of actin from the spine tip to the neck ([@bib29]; [@bib24]). These findings are consistent with models of actin array treadmilling, in which new actin molecules are incorporated at actin filament barbed ends, predominantly located close to the plasma membrane ([@bib38]; [@bib31]; [@bib15]). These models suggest that actin polymerization is favored in this juxtamembrane region, or 'shell' of the spine. Conversely, though, disassembly/severing must be favored towards the center of the spine head ('core'), both to prevent filament overgrowth and to supply new actin monomers for ongoing treadmilling.

Many proteins likely contribute to the intra-spine balance of actin filament polymerization/ depolymerization. However, a key generator of actin monomers is cofilin, which enhances filament disassembly by severing 'aged' regions of filaments (those in which ADP-actin subunits predominate, usually toward filament pointed ends \[[@bib44]\]). It has been hypothesized that in order for treadmilling to occur normally, LIMK1 may need to phosphorylate and inhibit cofilin specifically in juxtamembrane regions ([@bib57]). How such spatially precise cofilin regulation might be achieved has been unclear, but could be aided by the enrichment of active, palmitoylated LIMK1 on the spine membrane. Juxtamembrane-specific phosphorylation of cofilin by palmitoyl-LIMK1 would be predicted to locally favor actin filament polymerization to maintain or, in response to local synaptic cues, rapidly expand the size of the spine head. Conversely, palmitoyl-LIMK1\'s absence from the spine core would allow cofilin to remain active and disassemble/sever actin filaments, ensuring a supply of actin monomers for treadmilling and limiting excess filament polymerization. A key 'security feature' of this model is that inappropriately localized (depalmitoylated) LIMK1 is inactive in neurons and thus would not adversely affect such spatially precise cofilin regulation.

In support of this model, the phosphatase Slingshot-1L, which dephosphorylates and activates cofilin, is active only when bound to actin filaments ([@bib49]; [@bib61]) and would thus be predicted to be less active in juxtamembrane regions. However, we emphasize that such a cofilin gradient model is speculative, and that overall cofilin activity in spines is likely controlled not only by LIMK1, but also by proteins such as Actin-interacting protein-1 (Aip1) that regulate cofilin activity, and those such as Coronins that control cofilin-actin binding ([@bib52]; [@bib16]; [@bib37]). Nonetheless, an intriguing possibility arising from this model is that palmitoylation of signaling enzymes (discussed further below) is used by neurons to establish or maintain polarized (shell-to-core, or edge-to-center) signaling gradients.

What lies upstream of LIMK1 palmitoylation? {#s3-6}
-------------------------------------------

Another key question regards how LIMK1 palmitoylation is regulated in spines. Changes in neuronal activity acutely alter palmitoylation of a subset of synaptodendritic proteins ([@bib34]). However, our preliminary findings suggest that LIMK1 does not fall into this category, because LIMK1 palmitoylation in ABE assays is unaltered by treatment of neurons with Bicuculline or KCl (JG and GT, unpublished observations). However, it is still possible that extracellular stimuli, particularly those such as ephrins that acutely regulate spine dynamics via PAK ([@bib53]), may dynamically alter LIMK1 palmitoylation. In addition, limitations of the ABE assay (which detects the entire cellular complement of palmitoyl-LIMK1, irrespective of location) could mask selective changes in LIMK1 palmitoylation at spines.

It is also unclear which PAT(s) controls LIMK1 palmitoylation in spines. Multiple PATs can palmitoylate LIMK1 in cotransfected HEK293T cells, including both Golgi-localized and synaptodendritic PATs (JG and GT, unpublished observations). This finding suggests that no single PAT is likely to control LIMK1 palmitoylation. It is also unclear whether the activity of LIMK1\'s upstream activators PAK and/or CaMKII is required for LIMK1 palmitoylation. These are all interesting questions to address in the future.

New roles for palmitoylation in the spatial control of neuronal signaling {#s3-7}
-------------------------------------------------------------------------

Two broader points that emerge from our findings is that palmitoylation can ensure spatially precise control of actin regulation and of kinase signaling. With this in mind, it is interesting that the actin regulators profilin and coronin are also likely palmitoylated ([@bib34]), suggesting that palmitoylation may control multiple aspects of spine-specific actin regulation.

In addition, recent reports ([@bib64]; [@bib71]) and our own ongoing experiments (in which we have identified several other palmitoyl-kinases; JG and GT, unpublished observations) suggest that signaling by other kinases is palmitoylation-dependent. Moreover, numerous other signaling enzymes contain predicted palmitoylation sites similar to those found in LIMK1 (not shown). Neurons may thus broadly use palmitoylation to localize diverse groups of signaling enzymes to enhance the spatial specificity of myriad intracellular signaling events.

Links between LIMK1 palmitoylation, cytoskeletal regulation and cognitive function {#s3-8}
----------------------------------------------------------------------------------

Aberrant regulation of the spine actin cytoskeleton is strongly linked to impaired cognition. There has been considerable interest in LIMK1 in this regard, due to *LIMK1\'*s frequent genetic deletion in Williams syndrome ([@bib23]; [@bib65]) and the impaired performance of *LIMK1* knockout mice in learning tasks ([@bib43]). This latter phenotype was linked to impaired spine morphology, but whether LIMK1 acts directly in spines was unclear. Our results strongly support this hypothesis and further implicate LIMK1 palmitoylation as critical for the control of spine structure. Moreover, differential spine targeting of LIMK1 and LIMK2 ([Figure 3](#fig3){ref-type="fig"}) may explain LIMK2\'s failure to compensate following loss or mutation of LIMK1.

We do, however, note some differences between effects of germline *LIMK1* knockout ([@bib43]) and LIMK1 knockdown in mature neurons (this study). In particular, conventional *LIMK1* knockout mainly affects spine morphology and PSD size, while LIMK1 knockdown reduces spine and synapse numbers. The more subtle effects of conventional *LIMK1* knockout may be due to developmental compensation by other pathways. Indeed, acute knockdown of other synaptic proteins causes more dramatic effects than germline knockout ([@bib20]). Nonetheless, our findings strengthen links between LIMK1 and the control of spine morphology and plasticity, both of which are linked to higher brain function.

Finally, spine-associated impairments in the absence of palmitoyl-LIMK1 are reminiscent of phenotypes seen in human patients with Intellectual Disability and other cognitive disorders ([@bib21]; [@bib48]). Moreover, mutations in Rac/Cdc42 regulators, PAKs and LIMK1 are linked to disrupted spine morphology and impaired cognition ([@bib23]; [@bib65]; [@bib1]; [@bib48]). Our findings provide further evidence that a broadly similar mechanism (i.e., impaired cytoskeletal regulation in spines) may underlie many of these conditions.

Materials and methods {#s4}
=====================

Antibodies {#s4-1}
----------

The following antibodies, from the indicated sources, were used: purified myc 9E10 (Enzo Life Sciences, Farmingdale, NY); PSD-95 (K28/43) (Neuromab, UC Davis, CA); Synapsin I, chicken anti-GFP (EMD Millipore, Billerica, MA); mouse anti-GFP 3E6 (Life Technologies, Carlsbad, CA); LIMK1 (BD Biosciences, San Jose, CA); myc 9B11, LIMK2 8C11, PhosphoLIMK1(T508)/LIMK2(T505), cofilin, phospho-cofilin (Cell Signaling Tech, Danvers, MA); Tubulin (Sigma, St. Louis, MO).

Chemicals {#s4-2}
---------

2-Bromopalmitate and S-Methyl methanethiosulfonate (MMTS) were from Sigma. All other chemicals were from ThermoFisher Scientific (Waltham, MA) and were of the highest reagent grade.

Molecular biology and cDNA clones {#s4-3}
---------------------------------

Human LIMK1 and LIMK2 cDNAs were from Arizona State University plasmid repository. A C-terminal myc tag was added to LIMK1 and LIMK2 by PCR and the resultant fragments were subcloned into the mammalian expression vector pRK5 and the lentiviral vector FUW ([@bib39a]). CCSS-LIMK1-myc (Cys 7, 8 of LIMK1 mutated to Ser), SC-LIMK1-myc and CS-LIMK1-myc were generated by PCR using mutagenic primers. An N-terminal myristoylation sequence (MGQSLTT; \[[@bib70]\]) was added to the N-terminus of CCSS-, CS and SC LIMK1 mutants by PCR. A LIMK1 shRNA (GAACGTGGTGGTGGCTGAC) was subcloned into a modified FUGW vector ([@bib39a]) downstream of an H1 promoter, and its effectiveness was confirmed against cotransfected rat LIMK1-myc cDNA (purchased from Origene, Rockville, MD). The GFP cassette of FUGW was removed and mCherry cDNA inserted to generate FUmChW. ShRNA resistant (shr) wt- and CCSS- LIMK1-myc were generated by mutating the shRNA target region while maintaining protein-coding sequence. Shr-wt- and CCSS-LIMK1-GFP were generated by PCR amplification of shr-wt- and shr-CCSS-LIMK1 cDNAs, without the myc tag and subsequent ligation into eGFP-N2 vector (Clontech, Mountain View, CA).

Bioinformatic identification of LIMK1 as a predicted palmitoyl-protein {#s4-4}
----------------------------------------------------------------------

Two bioinformatic approaches were used to identify palmitoylated actin regulators. First, we searched for known actin regulators among the top 'hits' in a database of predicted palmitoyl-proteins, originally generated using the CSS-Palm prediction program ([@bib55]). Second, we used the Regular Expression function of Scansite ([@bib50]) to identify known actin regulatory proteins that contain CXC or CC motifs (C: cysteine; X: any amino acid) within their first 10 residues, as motifs of this type are frequently palmitoylated ([@bib25]).

Cultured hippocampal neurons {#s4-5}
----------------------------

Hippocampi were dissected from E18 rat embryos and neurons were cultured in Neurobasal/B27 as described ([@bib66]). All animal use protocols were approved by the Institutional Animal Care and Use Committee of Temple University.

Acyl Biotinyl exchange assay (ABE) {#s4-6}
----------------------------------

ABE was performed essentially as described ([@bib66]). For ABE experiments, transfected HEK293T cells or neurons were lysed directly in buffer containing 50 mM HEPES pH 7.0, 2% SDS, 1 mM EDTA plus protease inhibitor cocktail (PIC, Roche, Indianapolis, IN) and 20 mM methyl-methane thiosulfonate (MMTS, to block free thiols). Excess MMTS was removed by acetone precipitation and pellets were resuspended in buffer containing 4% (wt/vol) SDS. BCA assays (Life technologies, Grand Island, NY) were performed to normalize total protein amounts when samples from different developmental stages were compared. Samples were diluted and incubated for 1 hr at room temperature in either 0.7 M hydroxylamine pH 7.4 (to cleave thioester bonds) or 50 mM Tris pH 7.4. Acetone precipitation was performed to remove hydroxylamine or Tris. Pellets were resuspended in 4% (wt/vol) SDS, diluted in 50 mM Tris pH 7.4 containing sulfhydryl-reactive (HPDP-) biotin and incubated for 1 hr at room temperature. Unreacted HPDP-biotin was removed by acetone precipitation and pellets were resuspended in lysis buffer without MMTS. Samples were diluted to 0.1% (wt/vol) SDS and biotinylated proteins were affinity-purified using neutravidin-conjugated beads. Beta-mercaptoethanol (1% \[vol/vol\]) was used to cleave HPDP-biotin and release biotinylated proteins from the beads. The released proteins in the supernatant were denatured in SDS sample buffer and processed for Western blotting with LIMK1 antibodyABE assays and all other biochemical experiments were performed at least 3 times. In each case a representative experiment is shown.

Lentiviral infection and shRNA knockdown {#s4-7}
----------------------------------------

VSV-G pseudotyped lentivirus was produced in HEK293T cells as described ([@bib66]). Briefly, HEK293T cells were cotransfected with FUGW or FUmChW vectors (with or without LIMK1shRNA) plus VSV-G, pMDLg and RSV-Rev helper plasmids. Supernatant containing virus was harvested 48 and 72 hr post-transfection, concentrated by ultracentrifugation, resuspended in Neurobasal medium and used to infect neurons at DIV9. Neurons were lysed at DIV15.

Pharmacological treatments {#s4-8}
--------------------------

2-Bromopalmitate was prepared as a 100 mM stock in ethanol and used at 100 µM final concentration. Sister cultures were treated with solvent control (0.1% \[vol/vol\] ethanol).

Transfection and immunocytochemistry {#s4-9}
------------------------------------

HEK293T cells were transfected as described ([@bib68]). Hippocampal neurons on coverslips were transfected at DIV13-18 using Lipofectamine 2000 (Invitrogen) as described ([@bib66]). For immunocytochemistry, neurons were fixed in 4% (wt/vol) paraformaldehyde, 4% (wt/vol) sucrose in phosphate-buffered saline (PBS), washed with PBS and permeabilized with PBS containing 0.25% (wt/vol) Triton X-100. After brief PBS washes, coverslips were blocked for 30 min at room temperature in 10% (vol/vol) normal goat serum (NGS) diluted in PBS, incubated overnight at 4°C with primary antibodies (in NGS/PBS) and then with AlexaFluor-conjugated secondary antibodies for 1 hr at room temperature. For localization experiments, neurons were always fixed \<24 hr post-transfection.

Image acquisition and analysis of dendritic spine morphology and synaptic puncta {#s4-10}
--------------------------------------------------------------------------------

For confocal imaging of fixed neurons, Z-stack images (0.2 µm spacing, 1024 × 1024 pixel resolution) were acquired using a Nikon C2 inverted confocal microscope with a 60× oil immersion objective (1.4 NA, plan-Apo). Acquisition parameters (laser power, gain and offset) were kept constant between all conditions. Maximum intensity projections were generated using NIS Elements software and used for mask analysis of mean intensities for spine to shaft intensity ratio and colocalization for synaptic puncta.

Analysis of spine targeting ratio, intensity profiles and spine morphology {#s4-11}
--------------------------------------------------------------------------

Quantitative analysis of fluorescent intensity line profiles and spine to shaft ratio of confocal stacked images were performed using Nikon NIS-Elements AR software. To quantify spine to shaft targeting ratios, dendritic spine were identified in the GFP channel. The fluorescent intensities of myc signals in spine heads and directly adjacent shaft regions were manually measured using intensity profile tool (crossed lines) of NIS-Elements. Soma intensity profiles were constant in all images measured. Average intensities of spines and adjacent shaft regions were exported to Excel, ratios were calculated and data were plotted using Graphpad Prism. To determine the morphologies of dendritic spines, the outline of the dendrite, including all spines, was manually traced using the signal from a morphology marker (usually GFP). Area, length and head width of each spine was then measured by Metamorph software (Molecular Devices).

FRAP of GFP-actin {#s4-12}
-----------------

Hippocampal neurons (DIV17) were transfected with GFP-β actin plus mCherry cDNAs as above. 24 hr later, neurons were transferred to a live imaging chamber (Warner Instruments) in recording buffer ([@bib66]), containing (in mM) HEPES 25, NaCl 120, KCl 5, CaCl2 2, Glucose 30 and MgCl2 1 (pH 7.4). The chamber was assembled on the Nikon C2 confocal microscope stage. Neurons were identified based on the cotransfected morphology marker mCherry. Images of dendritic segments were then acquired for both mCherry and GFP-actin signals, using 10× optical zoom with acquisition settings of 256 × 256 pixel resolution at 2% laser power. After acquiring images from both channels, FRAP was performed only on the GFP-actin channel. Prebleach fluorescent signal was acquired using a 488 nm line argon laser and recorded using a 500--550 nm band pass filter. A circular Region of Interest (ROI, 2 µm diameter) on a selected dendritic spine head was photobleached by scanning with the 488 nm argon laser line at 100% laser power with pixel dwell time of 2.2 µs. (Prebleach: 3 frames at 2 s intevals; photobleach 3.74 s, postbleach acquisition, 20 frames at 2 s intervals, 20 frames at 5 s intervals and 10 frames at 20 s intervals). Average fluorescence in the ROI was measured and background was subtracted. Decrease in fluorescence monitored in nearby reference ROIs was minimal under these conditions. Fluorescence intensity was normalized to baseline (average of all pre-bleach measurements) and plotted as a function of time.

We used two different methods to quantify the extent, and another two methods to quantify the kinetics, of post-bleach recovery of GFP-actin fluorescence. For all methods we first subtracted any remaining signal at the first post-bleach time point, and renormalized the data after setting this point as 0, as described previously ([@bib35]).

For the first method to calculate the stable fraction of GFP-actin, we calculated the mean fluorescence of each trace during the period 250--300 s post-bleach, when recovery of the dynamic component fluorescence is essentially complete ([@bib35]). This value was defined as the mobile fraction, and the stable fraction was defined as (1 − \[mobile fraction\]). All means per condition were then used for statistical comparison.

We also used a previously described method ([@bib29]; [@bib35]) to calculate the stable fraction of GFP-actin. Briefly, after plotting the normalized values of each individual set of FRAP data, a linear extrapolation of each curve in the region exceeding approximately 5 × t~1/2\ (dynamic)~ was made. The y intercept value was taken as the size of the mobile fraction, and the stable fraction was then calculated as above. Both these methods to determine the stable fraction of GFP-actin gave similar results.

To determine the recovery half-time, we used the same plots and determined the time point at which the dynamic component reached half the value of its maximal recovery ([@bib35]). We also calculated recovery half-times by fitting data from the recovery phases of each individual trace to the equation y(t) = y~0~ + (Plateau---y~0~) × (1 − e^−t/t1^ ) where y~0~ is the fluorescence value immediately post-bleach, Plateau is the y value at infinite times and t~1~ is the time constant of recovery (similar to the method of \[[@bib36]\]). Again, both methods to calculate the kinetics of recovery gave very similar results.

FRAP of LIMK1-GFP {#s4-13}
-----------------

FRAP experiments for LIMK1-GFP were performed essentially as for GFP-actin, except that neurons were transfected with mCherry plus either wild type LIMK1-GFP or CCSS-LIMK1-GFP cDNAs. Traces were analyzed as for GFP-actin, except that half-times of recovery were only determined by the curve-fitting method, because the fluorescence signal for CCSS-LIMK1-GFP had not reached a plateau at the last time point examined. For the same reason, the linear extrapolation method was not used to determine the stable fraction for these experiments.

Organotypic slice culture and biolistic transfection {#s4-14}
----------------------------------------------------

Hippocampal sections (400 μm) were prepared from P7-8 Sprague Dawley rats using a MX-TS tissue slicer (Siskyou, Grants Pass, OR) and cultured on 0.4 μm cell culture inserts at 34°C as described ([@bib60]). At DIV 8--10, neurons were transfected biolistically using a hand-held gene gun (Bio-Rad, Irvine, CA). For preparation of gene gun cartridges, 30--60 μg of DNA was added to 8--10 mg of 1.0 μm gold microcarriers (Biorad). Neurons were returned to the incubator for 3--4 days prior to imaging.

Two photon glutamate uncaging {#s4-15}
-----------------------------

Transfected organotypic slices were transferred to an imaging chamber on a BX61WI upright microscope (60×/1.0 NA objective; Olympus) and continuously perfused at room temperature in ringer solution containing (in mM): 119 NaCl, 2.5 KCl, 0.1 MgSO~4~, 3.0 CaCl~2~, 1.0 NaH~2~PO~4~, 11 glucose, and 26.2 NaHCO~3~, 0.01 glycine, 0.001 TTX and 2.5 MNI-Glutamate (Femtonics, Manassas, VA). For the morphological plasticity experiments, mCherry signal was imaged at 950 nm using a Ti:Sapphire pulsed laser (MaiTai-DeepSee, Spectra Physics, SantaClara, CA) and MNI-Glutamate was uncaged with a second laser tuned at 720 nm. Short segments of secondary and/or tertiary apical dendrites were continuously imaged at 1--2 min intervals by gathering z-stacks (0.75 μm steps) centered on the spine of interest. The glutamate uncaging protocol consisted of 4 ms pulses delivered at 0.5 Hz for 1 min ([@bib28]). Laser power of the uncaging beam was fixed across experiments at 30 mW, measured at the back aperture of the objective. Parallel electrophysiological experiments (n \> 50) showed that uncaging at this laser power consistently yields AMPAR-mediated inward currents between 5--30 pA. Experiments were performed on spines at approximately constant depth to minimize uneven light scattering between experiments.

To monitor changes in uncaging-evoked excitatory postsynaptic currents (uEPSCs) during single-spine LTP, CA1 neurons were voltage clamped at −70 mV with an internal solution containing (in mM): 115 cesium methane-sulfonate, 5 tetraethylammonium-Cl, 10 sodium phosphocreatine, 20 HEPES, 2.8 NaCl, 5 QX-314, 0.4 EGTA, 3 ATP(Mg^2+^ salt), and 0.5 GTP, and 0.02 Alexa 594 (pH 7.25, 280--290 mOsmol/l). Neurons were continuously perfused in a ringer solution containing (in mM): 119 NaCl, 2.5 KCl, 1.3 MgSO~4~, 2.5 CaCl~2~, 1.0 NaH~2~PO~4~, 11 glucose, and 26.2 NaHCO~3~, 0.01 glycine, 0.001 TTX, and 2.5 mM MNI-Glutamate. Ti-sapphire lasers were tuned to 810 nm and 720 nm for imaging of Alexa 594 and uncaging of MNI-glutamate, respectively ([@bib60]). Shortly after gaining whole cell access (\<5 min), short duration light pulses (4 ms) were delivered at low frequency (0.05 Hz) to the tips of two adjacent dendritic spines to uncage MNI-Glutamate and establish a baseline uEPSC amplitude for each spine. Neurons were then voltage clamped at 0 mV and 30 consecutive light pulses were delivered to a single spine at 0.5 Hz to induce LTP ([@bib28]). This pairing protocol was performed less than 6 min after gaining whole cell access to avoid potential issues associated with washout ([@bib41]). uEPSCs (at −70 mV) were then monitored for an additional 20 min at 0.05 Hz. Two-photon image stacks (810 nm) of the dendritic segment was sampled approximately every 5 min. To monitor changes in spine volume during these experiments, we measured the intensity of Alexa594 signal in both the stimulated and unstimulated spine. Because the intracellular dye concentration was typically not at a steady state under these conditions, we normalized spine intensities to the intensity of a nearby dendritic segment at each time point.

Analysis of 2P uncaging-induced changes in spine volume {#s4-16}
-------------------------------------------------------

For MNI-glutamate uncaging experiments, a stackreg function in ImageJ (NIH) was used to align maximum intensity projected images from each time series to correct for X--Y drift. Changes in spine volume were estimated using an intensity-based method by summing pixel intensities from spine regions of interest at each time point, as described previously ([@bib28]). The average summed intensity of the first four baseline images (prior to uncaging) was used as F~o~ and all intensity values are plotted as ΔF/F~o~ × 100. All summed intensity measurements were background subtracted and gathered from raw unprocessed images. Spine 'growth success' and spine 'shrinkage' events reflect instances where the average normalized intensity values remained above, or below, 2× the SD of the baseline (±16% for growth success and spine shrinkage, respectively) for the duration of the experiment after glutamate uncaging. Spine diameter measures ([Figure 5](#fig5){ref-type="fig"}) were estimated based on a full width at half maximum value (in μm), calculated by applying a Gaussian fit to the intensity profile across the spine head of the first baseline image.

Quantification of synaptic puncta {#s4-17}
---------------------------------

Synaptic puncta in transfected neurons were defined as signals that were positive for GFP (morphology marker), PSD-95 (postsynaptic marker) and Synapsin (presynaptic marker). Synaptic puncta per unit length of dendrite were quantified using NIH ImageJ software. Briefly, PSD-95 and Synapsin images in each channel were thresholded by gray value at a level close to 50% of the dynamic range. This threshold value was kept constant for all images in each condition, and background noise from these images were negligible. The GFP fill was used to trace 100 µm segments along the three most prominent dendrites emanating from the cell body. Synaptic puncta of 2--20 pixel units, defined as above, were measured using the Boolean function 'AND' for the selected channels within each dendritic segment. Results were logged to a spreadsheet.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Palmitoylation of LIM Kinase-1 Ensures Spine-specific Actin Polymerization and Morphological Plasticity" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and three reviewers, one of whom, Pekka Lappalainen, is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before reaching the decision. As you will see, they all considered your findings on LIMK1 palmitoylation important and interesting, and found majority of the data convincing and of high technical quality. However, they stated that a few additional experiments are required to strengthen the conclusions presented, and that the manuscript text and some figures should be revised. Most importantly, it appears that palmitoylation has a more complex role in LIMK1 localization and function in spines than proposed in the present version of the manuscript. Furthermore, the model concerning cofilin activity gradient generated solely by LIMK1 activity was not found particularly convincing.

Major comments (required):

1\) Does dipalmitoylation of LIMK1 simply function in membrane anchoring or does the membrane insertion of this region alter the interactions of the LIMK1 N-terminus with other binding partners? This could be tested by using a N-myr mutant protein with a single cysteine in the palmitoylation region (CS or SC) such that a doubly acylated N-terminal tail (myristate and palmitate) would be expressed in cells. Would this behave identically to the dipalmitoylated species? Unless the N-terminal myristoylation interferes with recognition of the palmitoylation domain by the PAT, this experiment should be easily done. If the Myr/Palm form accumulates to spines, is it activated normally by signaling through Pak?

2\) The FRAP data presented in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"} should be properly fitted and analyzed. In addition to examining the sizes of immobile fractions, the authors should obtain information about the dynamics of the mobile fractions. Furthermore, it would be important to perform FRAP analysis also on GFP alone as a control for [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}, (i.e. to measure the dynamics of a truly soluble protein in spines). Overall, the data presented in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} suggest that both wild-type and CCSS-LIMK1 display very slow dynamics in spines, indicating that LIMK1 associates with other proteins that severely limit its diffusion at these sites. Thus, palmitoylation seems to play a more complex role in LIMK1 localization and function that just anchoring this protein to the plasma membrane. Moreover, the results of FRAP analysis presented in [Figure 5](#fig5){ref-type="fig"} should be more precisely discussed by considering the known functions of LIMK1 and ADF/cofilins.

3\) Actin dynamics and structural plasticity of dendritic spines have been associated with the maintenance and plasticity of "functional" strength of excitatory synapses. Demonstrating the importance of LIMK1 palmitoylation in the maintenance of excitatory synaptic transmission and glutamate uncaging-induced functional plasticity would thus significantly strengthen the manuscript.

Other comments:

1\) The "shell-to-core" cofilin activity gradient hypothesis is not sufficiently well supported by the data in the present study. Therefore, the manuscript text and Figure 10 should be accordingly modified.

2\) To provide the readers more balanced view on the mechanisms regulating cofilin activity in cells, it would be important to discuss the possible roles of phosphatases and other interacting proteins in regulating cofilin activity and actin dynamics in dendritic spines.

3\) The palmitoyl acyltransferase data ([Figure 4](#fig4){ref-type="fig"}) are not particularly convincing, and should be either significantly strengthened or omitted from the manuscript.

4\) The authors should discuss what lies upstream of LIMK1 palmitoylation in neurons.

Below, please also find the specific comments by the three reviewers. These will provide you additional information about how to deal with the points listed above.

*Reviewer \#1*:

Precisely controlled actin filament assembly and disassembly are crucial for morphogenesis of dendritic spines in neurons. However, the spatial mechanisms controlling actin dynamics in spines are incompletely understood. Here, George et al. identify palmitoylation of LIMK1 as an important mechanism controlling actin dynamics in spines. They show that palmitoylation is critical for enrichment of LIMK1 (but not LIMK2) in spines and for its activation at these sites. Consequently LIMK1 palmitoylation is important for proper regulation of actin dynamics and long-term stability of dendritic spines.

The majority of the experiments presented appear to be of good technical quality, and the manuscript provides important new information concerning the spatial control of actin dynamics in neurons as well as on the mechanisms that control the subcellular localization of LIMK1. However, there are few important points that should be addressed to improve the study.

1\) The results of FRAP experiments presented in [Figure 5](#fig5){ref-type="fig"} are somewhat confusing, and the authors should perform better analysis of the FRAP data. From the data presented in [Figure 5D](#fig5){ref-type="fig"}, it seems that that the actual rates of fluorescence recovery are quite similar in all cases (although this should be carefully examined by fitting the data). However, LIMK1 knockdown and CCSS-LIMK1 rescue cells exhibit a significantly larger immobile fraction of actin compared to control cells. Thus, while majority of actin filaments in control cells undergo relatively rapid turnover, approximately 30 % of actin filaments in LIMK1 (and CCSS-LIMK1 rescue spines) appear to be very stable. How does inactivation of LIMK1, which is a negative regulator of ADF/cofilin-mediated rapid actin filament disassembly, result in appearance of a stable actin filament pool in spines (because increased ADF/cofilin activity would be expected to increase (not decrease) actin filament turnover in spines)? This surprising result should be discussed in the \'Results\' and \'Discussion\' sections in more detail. Furthermore, the FRAP data should be properly fitted and analyzed as described e.g. in Koskinen et al., (Mol. Cell. Neurosci., 2014) to obtain information about the dynamics of the mobile actin fraction.

2\) Similarly, the FRAP experiments shown in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} provided somewhat surprising results, and should be analyzed and discussed more carefully. Based on these experiments, it seems that both wild-type LIMK1 and CCSS-LIMK1 display very slow dynamics in spines. This indicates that LIMK1 associates in spines with other proteins that severely limit its mobility. To understand the dynamics of wild-type LIMK1 and CCSS-LIMK1 in spines, the authors should perform similar data fitting as requested for GFP-actin above as well as perform FRAP analysis on GFP alone as a control (i.e. to measure the dynamics of a truly soluble protein in spines). Overall, these data seem to suggest that palmitoylation is not required to immobilize LIMK1 in spines, but rather plays a more complex role in localizing this protein to dendritic spines and regulating its activity at these sites.

3\) The data presented in [Figure 4](#fig4){ref-type="fig"} are not particularly convincing and could perhaps be deleted from the manuscript. Is it possible that the differences in LIMK1 and NPY co-localization as well as in LIMK1 targeting to spines after brefeldin A treatment in proximal vs. distal regions could result from differences in the rate of depalmitoylation at these regions (instead of different palmitoyl acyltransferases interacting with LINK1 at different regions of dendrites)?

*Reviewer \#2*:

This manuscript by George et al reports the role of LIMK1 palmitoylation in the regulation of actin polymerization and morphological plasticity in dendritic spines. In support of this, the authors show that LIMK1 is palmitoylated at the N-terminal double cysteines, and that this modification promotes spine localization of the protein. Functionally, this palmitoylation is required for actin polymerization and stability of dendritic spines, and also for activity-dependent spine volume increase. Lastly, LIMK1 palmitoylation promotes LIMK1 activation (T508 phosphorylation), which requires CaMKII and PAK activation.

This is an interesting identification of a novel synaptic protein that is modified by palmitoylation, and demonstration of a novel role of a protein palmitoylation in the regulation of synaptic actin polymerization and activity-dependent structural plasticity of dendritic spines. Given the importance of actin-regulatory mechanisms in dendritic spines, and the known involvement of LIMK1 in cognitive impairments in humans, this study seems to have a significant impact in the field.

1\) This study mainly monitors actin polymerization and activity-dependent changes in spine volume as functional measures of the proposed mechanisms. However, actin dynamics and structural plasticity of dendritic spines have been keenly associated with the maintenance and plasticity of "functional" strength of excitatory synapses. Demonstrating the importance of LIMK1 palmitoylation in the maintenance of excitatory synaptic transmission and glutamate uncaging-induced functional plasticity would much strengthen the manuscript.

2\) It is unclear what lies in the upstream of LIMK1 palmitoylation. Is NMDAR activation required? Is the activation of CaMKII or PAK required for LIMK1 palmitoylation? Which PATs are involved in LIMK1 palmitoylation? Is the T508 phosphorylation of LIMK1 required for its palmitoylation? These aspects are all unclear and should be explored to some extent or, less ideally, discussed. Some questions marks can be added to the summary diagram in Figure 10.

*Reviewer \#3*:

Summary: In this very well written manuscript, the authors clearly demonstrate that the double cysteine motif at residues 7 and 8 of LIM kinase 1, which is not present in LIMK2, serves as a site for dipalmitoylation. This motif is both necessary and sufficient to target and anchor LIMK1 within dendritic spines. Interestingly, the authors find a brefeldin A-dependent and independent mechanism for spine delivery of palmitoylated-LIMK1, the former being used to supply proximal spines within about 100 μm of the soma and the latter used to deliver palmitoylated LIMK1 to distal spines. The activation of LIMK1 in spines by Pak is shown to be dependent upon LIMK1 palmitoylation, although in vitro, soluble active Pak can phosphorylate wild type and the non-palmitoylatable mutant CCSS-LIMK1 equally well. Studies on actin assembly dynamics using fluorescence recovery after photobleaching (FRAP) in spines of neurons expressing WT and mutant forms of LIMK1 show that normal dynamics and spine enlargement driven by glutamate stimulation requires palmitoylated LIMK1.

Critique: The sound experiments presented and the high quality results shown in the figures require very little comment. However there are some results that are missing which would be welcome additions to what is presented.

A question remains as to the role of the dipalmitoylation---is it simply membrane anchoring or does the membrane insertion of this region alter the interactions with other binding partners of the LIMK1 N-terminus? I am surprised that the authors did not use the N-myr mutant protein with a single cysteine in the palmitoylation region (CS or SC) such that a doubly acylated N-terminal tail (myristate and palmitate) resulted. Would this behave identically to the dipalmitoylated species? Unless the N-terminal myristoylation interfered with recognition of the palmitoylation domain by the PAT, this experiment should be easily done. If the Myr/Palm form is bound to membrane in spines, is it activated normally by signaling through Pak?

The evidence for the Golgi-dependence for proximal spine delivery of the palmitoylated LIMK1 is very strong, but the evidence for distal spine delivery requiring localized PAT activity is speculative. Although this mechanism is certainly possible, it may not be the only possibility for distal delivery. Until somatodendritic PATs can be down regulated differentially from those at the Golgi, it may remain a speculation.

In spite of the very high quality work shown in the studies presented here, there are still many unanswered questions regarding the model put forward to explain the centripetal retrograde flow of actin subunits that are adding onto actin filaments at the spine periphery and disassembling in the center. In this regard it is incorrect to talk about cofilin as "severing filament pointed ends" (in the subsection headed "Polarized "shell-to-core" actin regulation in spines by palmitoyl-LIMK1") and referencing the 2003 Pollard and Borisy review. Severing can occur anywhere in the filament where ADP-actin subunits predominate (which is generally more toward the pointed end of dynamic filaments). However, the type of turnover of these branched networks that is occurring is more correctly termed array treadmilling and there are many more current reviews, one of which should be cited for this. Given that the authors favor a cofilin gradient model, it is surprising that the Discussion fails to include a reference to work published from the Zheng lab in Nature Neuroscience (Gu J, et al., Nat Neurosci 13, 1208-1215, 2010) in which cofilin inhibition by LIMK1 was required for LTP-induced spine enlargement, a role proposed here for the LIMK1 in spines.

The speculative model that focuses on the possibility of a cofilin activity gradient also requires some comment. There are many additional factors that need to be considered. First, for cofilin to be regulated in such a manner its concentration would have to be quite low in spines and one would expect the phosphatases, which regulate its activation, would also need to be localized to the central domain because their activity seems to dominate the phosphorylation state of cofilin (see Gu paper referenced above and others). There is evidence that slingshot-1L, a major cofilin phosphatase is only active when bound to F-actin, a fact that could help support the gradient model (Nagata-Ohashi K, et al. J Cell Biol. 165: 465-471, 2004: Soosairajah J, et al., EMBO J 24, 473-486, 2005). However, other studies suggest that the actin filament severing activity of cofilin is modulated (enhanced) in vivo by Aip1 (see recent Chen et al., J Biol Chem, 290: 2289-2300, 2015 and references theirin) and that cofilin\'s recruitment to F-actin is also modulated by coronin 1A (Kueh HY et al., J Cell Biol. 182:341-353, 2008). These proteins likely impact the actin dynamics and retrograde flow. Finally, many (perhaps all?) spines may undergo transient penetration by microtubules (Merriam EB, et al., J Neurosci 33: 16471-82, 2013)), whose assembly may also be modulated in a LIMK1-dependent manner by p25/TPPP, a protein that affects HDAC activity and acetylation of MTs (Acevedo K, et al., Exp Cell Res, 313, 4091-4106, 2007; Schofield AV, et al., J Biol Chem 288: 7907-17, 2013). I am not trying to argue for any one of these models, but simply believe that in this paper the authors have not convinced me that a gradient of cofilin activity exists nor that cofilin is the only target involved in regulating the actin dynamics. Maybe tone this model down a bit and remove the figure since such a figure is often what the reader will take away, even if totally speculative.

10.7554/eLife.06327.023

Author response

*1) Does dipalmitoylation of LIMK1 simply function in membrane anchoring or does the membrane insertion of this region alter the interactions of the LIMK1 N-terminus with other binding partners? This could be tested by using a N-myr mutant protein with a single cysteine in the palmitoylation region (CS or SC) such that a doubly acylated N-terminal tail (myristate and palmitate) would be expressed in cells. Would this behave identically to the dipalmitoylated species? Unless the N-terminal myristoylation interferes with recognition of the palmitoylation domain by the PAT, this experiment should be easily done. If the Myr/Palm form accumulates to spines, is it activated normally by signaling through Pak*?

We agree with the reviewers that analyzing LIMK1 mutants modified with myristate plus palmitate is an excellent way to gain more insight into the role of LIMK1 palmitoylation. As suggested, we therefore generated Myr-C7S and Myr-C8S LIMK1 mutants and assessed their localization and activation status in hippocampal neurons. Interestingly, neither mutant recapitulated the spine enrichment of wild type LIMK1, and neither mutant was as efficiently phosphorylated at T508. We have included these additional localization experiments in a new [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"} and have added the phosphorylation data to a modified [Figure 7](#fig7){ref-type="fig"} (renumbered following removal of [Figure 4](#fig4){ref-type="fig"}, as per the reviewers' suggestion). We mention in the legend to [Figure 7](#fig7){ref-type="fig"} that phosphorylation of Myr-C8S-LIMK1 differs significantly from that of Myr-CCSS-LIMK1, suggesting that, at least for this mutant, the myristoylation sequence does not interfere with recognition by the PAT. Taken together, these results suggest that myristate + palmitate modification is not equivalent to dipalmitoylation, and that an intact CC di-palmitoylation motif is essential to target LIMK1 to spines. Based on our accompanying pharmacological data ([Figure 8](#fig8){ref-type="fig"}), the spine enrichment of key 'upstream' kinases (activated forms of PAK and CaMKII) likely explains why LIMK1 mutants in other locations are not activated. We have modified the Discussion to include these new findings and to summarize how dipalmitoylation controls LIMK1 localization and signaling in neurons.

*2) The FRAP data presented in* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"} *and* [*Figure 5*](#fig5){ref-type="fig"} *should be properly fitted and analyzed. In addition to examining the sizes of immobile fractions, the authors should obtain information about the dynamics of the mobile fractions. Furthermore, it would be important to perform FRAP analysis also on GFP alone as a control for* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"}*, (i.e. to measure the dynamics of a truly soluble protein in spines). Overall, the data presented in* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"} *suggest that both wild-type and CCSS-LIMK1 display very slow dynamics in spines, indicating that LIMK1 associates with other proteins that severely limit its diffusion at these sites. Thus, palmitoylation seems to play a more complex role in LIMK1 localization and function that just anchoring this protein to the plasma membrane. Moreover, the results of FRAP analysis presented in* [*Figure 5*](#fig5){ref-type="fig"} *should be more precisely discussed by considering the known functions of LIMK1 and ADF/cofilins*.

We appreciate the need to more fully analyze our FRAP data and now include these additional analyses in updated versions of [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} (for LIMK1-GFP) and in both [Figure 4](#fig4){ref-type="fig"}, and a new [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"} (for GFP-actin; again, please note the adjusted numbering following removal of our original [Figure 4](#fig4){ref-type="fig"}).

For the GFP-actin experiments, we performed two analyses to determine the size of the stable fraction, both of which reinforced our initial conclusion that loss of palmitoyl-LIMK1 increases the fraction of stable actin. We also used two analytical methods to determine the kinetics of recovery of the dynamic fraction, both of which revealed that this is not significantly affected under any condition examined. In addition to updating the Figures as described above, we have modified the Methods section to include details of these additional analyses, which benefitted greatly from the reference kindly provided by Reviewer \#1 ([@bib35]).

Regarding our LIMK1-GFP FRAP experiments, we agree with the reviewer that both wild type and CCSS-LIMK1-GFP display very slow dynamics in spines. Our new analysis of the stable fraction of LIMK1-GFP in spines (modified [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}) supports the conclusion that CCSS mutation decreases the fraction of stable LIMK1. We also quantified the recovery times of the mobile pool for each LIMK1-GFP construct. Although the lack of wild type LIMK1-GFP fluorescence recovery makes determining the precise recovery kinetics difficult, (a point explained in the legend to [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}) both wt- and CCSS-LIMK1-GFP clearly recover markedly more slowly than freely soluble cytosolic proteins. We thus fully agree with the reviewer that these results suggest that LIMK1 associates with other proteins that limit its diffusion. Thus, although the effect of palmitoylation on stabilizing LIMK1 in spines is significant, it may be less critical than its roles in spine targeting ([Figure 1](#fig1){ref-type="fig"}), and in ensuring LIMK1 phosphorylation by spine-specific upstream activators ([Figures 7, 8](#fig7 fig8){ref-type="fig"}). We have modified our Discussion to include these points.

We also attempted to measure the kinetics of recovery of cytosolic GFP alone, but using the parameters for our GFP-actin and LIMK1-GFP FRAP experiments we found that cytosolic GFP fluorescence recovered too rapidly for us to accurately plot recovery curves. In the limited time available for revision we were unfortunately unable to re-optimize conditions for this experiment, but we note that several reports (e.g. [@bib62], Nat Neurosci; Sharma et al., 2006, Mol. Cell. Neurosci; [@bib76], J. Neurosci) have already demonstrated very rapid FRAP for cytosolic GFP in dendritic spines (time constant \<1 sec; [@bib62]). Moreover, another report ([@bib8], Cell 140, 567-578) found that FRAP of GFP-tagged Rpt1, a protein of similar size (75 kDa) to LIMK1-GFP (95 kDa) was also extremely rapid. We have modified both our Results and Discussion to include these points and note that they all support the reviewer's hypothesis that LIMK1 does not behave like a soluble protein and that other factors, most likely protein-protein interactions, markedly limit LIMK1 diffusion in spines.

Finally, in response to both this comment and to further points raised by Reviewers \#1 and \#3, we have considered our GFP-actin FRAP results with regard to known roles of LIMK1 and ADF/cofilins. We agree that the increase in immobile actin in the absence of palmitoyl-LIMK1 is surprising, given LIMK1's known roles. We have therefore modified our Results to highlight this finding and have included three possible explanations in the Discussion, which we summarize here:

One explanation for our results could arise from the ability of active (dephospho-) cofilin to induce a twist in actin filament conformation that propagates along the filament (e.g. [@bib5], Trends Cell Biol.). Filaments are more likely to sever at boundaries between cofilin-bound (twisted) and unbound (untwisted) regions ([@bib9], J. Mol. Biol.). However, an entire cofilin-bound filament, as might occur in the absence of LIMK1, is more stable than a bare filament ([@bib18], Biophys Chem; [@bib2], Mol. Cell). Thus, if cofilin phosphorylation is reduced in LIMK1 knockdown (and CCSS-LIMK1 'rescue') spines, then these spines may contain a subset of filaments that are decorated with active cofilin but which are actually more stable.

A second, related possibility is that increased levels of dephospho-cofilin, caused by loss of palmitoyl-LIMK1, may enhance formation of cofilin-actin rods. Rods are stable structures that are only formed by dephospho-cofilin and actin turnover within rods is very slow ([@bib7], Am. J. Physiol. Cell Physiol.), which could account for the increased stable GFP-actin that we observe. However, we note that cofilin-actin rods have been documented in neurites but not, to our knowledge, within spines.

A third, intriguing explanation, which we favor, arises from a prior report that LTD-like stimulation (low frequency electrical stimulation or bath application of NMDA) markedly increases actin filament stability in spines ([@bib62], Nat Neurosci). Strikingly, as noted in our initial manuscript, the LTP-like stimuli used in our uncaging experiments result in shrinkage of a significant subset of spines (an [LTD]{.ul}-like effect) in the LIMK1 knockdown and CCSS-LIMK1 rescue conditions ([Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}). This suggests that 'learning rules' are impaired in some LIMK1 knockdown (and CCSS-LIMK1 rescue) spines, so that they respond to LTP-like inputs with LTD-like outputs. Spontaneous bursts of activity in our cultured neurons may therefore be interpreted as LTD-like stimuli by some LIMK1 knockdown spines. In the short term this would be predicted to decrease actin filament turnover, as reported by Star et al., while over longer times this impaired actin turnover may contribute to the spine shrinkage and synapse loss that we observe. We note in our revised Discussion that the three explanations above are not mutually exclusive and could all contribute to the impaired actin filament turnover in the absence of palmitoyl-LIMK1. Moreover, we also mention the possibility that other potential LIMK1 substrates, in addition to cofilin, may contribute to this effect.

*3) Actin dynamics and structural plasticity of dendritic spines have been associated with the maintenance and plasticity of* "*functional*" *strength of excitatory synapses. Demonstrating the importance of LIMK1 palmitoylation in the maintenance of excitatory synaptic transmission and glutamate uncaging-induced functional plasticity would thus significantly strengthen the manuscript*.

We appreciate and share the reviewers' interest in palmitoyl-LIMK1's role in the regulation of synaptic transmission and functional plasticity. We therefore performed new experiments to address whether the activity-dependent structural plasticity, which is palmitoyl-LIMK1-dependent ([Figure 5](#fig5){ref-type="fig"}), is accompanied by changes in functional plasticity. In a new [Figure 5--figure supplement 2](#fig5s2){ref-type="fig"} we now include important proof-of-principle experiments that confirm that our 2-photon uncaging stimulation reliably increases not only spine volume but also AMPA uncaging-evoked postsynaptic currents (uEPSCs), and that both changes are specific to the stimulated spine. Importantly, previous studies reported very similar molecular requirements for uncaging-induced structural and functional plasticity, and in particular identified key roles for both actin polymerization and Cdc42 signaling in both processes ([@bib42], Nature; [@bib46], Nature). Our new experiment therefore supports the hypothesis that LIMK1 palmitoylation may also be required for activity-dependent functional plasticity, and may be a key link between the Cdc42 signaling and actin polymerization described by others. We have modified our Discussion to include these important points. Finally, we note that in several studies that focused on mechanisms of spine cytoskeletal regulation using 2-photon uncaging (e.g. [@bib11], Neuron; Steiner et al., 2008, Neuron; Tanaka et al., 2008, Science), functional plasticity experiments were limited to confirming that the same uncaging protocol induces both structural and functional plasticity, as we now demonstrate.

*Other comments*:

*1) The* "*shell-to-core*" *cofilin activity gradient hypothesis is not sufficiently well supported by the data in the present study. Therefore, the manuscript text and Figure 10 should be accordingly modified*.

We appreciate this concern of the reviewers and have therefore modified the text of the Discussion accordingly. We also discuss other factors that may influence spatial control of filament polymerization/ depolymerization by palmitoyl-LIMK1, including other proteins that bind and/or affect activity of cofilin and/or additional LIMK1 substrates. Our discussion of these issues benefits greatly from (but is not limited to) the references kindly provided by Reviewer \#3, and we expand on these points in our reply to this reviewer below. In addition, we have modified Figure 10 to remove the gradient of cofilin activity, though we retained the schematic showing membrane-specific activation of palmitoyl-LIMK1.

*2) To provide the readers more balanced view on the mechanisms regulating cofilin activity in cells, it would be important to discuss the possible roles of phosphatases and other interacting proteins in regulating cofilin activity and actin dynamics in dendritic spines*.

As described in the reply to Point \#1 above, we agree with the need to discuss other regulators of cofilin activity and interactions and have modified the Discussion to include these points.

*3) The palmitoyl acyltransferase data (*[*Figure 4*](#fig4){ref-type="fig"}*) are not particularly convincing, and should be either significantly strengthened or omitted from the manuscript*.

To address this comment and to gain more insight into how LIMK1 palmitoylation is controlled, we performed a preliminary screen of all 23 mouse PATs (see also reply to Reviewer \#2 below). We identified both Golgi-localized PATs and synaptodendritic PATs that can palmitoylate LIMK1, a finding that is broadly consistent with our original hypothesis that LIMK1 palmitoylation occurs in both of these locations. However, we prefer not to include these data as we realize that significantly more work will be required to properly define how LIMK1 palmitoylation is controlled in neurons. We have therefore followed the reviewers' suggestion to remove [Figure 4](#fig4){ref-type="fig"}, and will address this question fully in future studies.

*4) The authors should discuss what lies upstream of LIMK1 palmitoylation in neurons*.

We agree that this point is worthy of further discussion and have modified the Discussion text to address it. We both summarize our PAT screening findings (in reply to Point \#3 above) and also discuss possible regulation of LIMK1 palmitoylation by neuronal activity or other factors. We mention additional preliminary findings that Bicuculline and KCl treatments do not increase LIMK1 palmitoylation, suggesting that LIMK1 is palmitoylation is likely constitutive. However, we also stress potential caveats regarding this conclusion, in particular the possibility that other stimuli could alter LIMK1 palmitoylation e.g. ephrins (which rapidly affect spine morphology via PAK) and/or that technical limitations of the ABE assay (which detects the entire cellular complement of palmitoyl-LIMK1, irrespective of location) could mask selective changes in LIMK1 palmitoylation at spines.

*Below, please also find the specific comments by the three reviewers. These will provide you additional information about how to deal with the points listed above*.

Reviewer \#1:

*1) The results of FRAP experiments presented in* [*Figure 5*](#fig5){ref-type="fig"} *are somewhat confusing, and the authors should perform better analysis of the FRAP data. From the data presented in* [*Figure 5D*](#fig5){ref-type="fig"}*, it seems that that the actual rates of fluorescence recovery are quite similar in all cases (although this should be carefully examined by fitting the data). However, LIMK1 knockdown and CCSS-LIMK1 rescue cells exhibit a significantly larger immobile fraction of actin compared to control cells. Thus, while majority of actin filaments in control cells undergo relatively rapid turnover, approximately 30 % of actin filaments in LIMK1 (and CCSS-LIMK1 rescue spines) appear to be very stable. How does inactivation of LIMK1, which is a negative regulator of ADF/cofilin-mediated rapid actin filament disassembly, result in appearance of a stable actin filament pool in spines (because increased ADF/cofilin activity would be expected to increase (not decrease) actin filament turnover in spines)? This surprising result should be discussed in the \'Results\' and \'Discussion\' sections in more detail. Furthermore, the FRAP data should be properly fitted and analyzed as described e.g. in Koskinen et al., (Mol. Cell. Neurosci., 2014) to obtain information about the dynamics of the mobile actin fraction*.

As described in our reply to the Major Comments, we appreciate the reviewer's concern and have analyzed our GFP-actin FRAP data accordingly. The additional analyses confirm the reviewer's assessment that, in both LIMK1 'knockdown' and CCSS-LIMK1 'rescue' neurons, there is an increased percentage of stable GFP-actin, but no significant effect on the kinetics of the remaining mobile GFP-actin. We have added these data in a new [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"} (renumbered following removal of our original [Figure 4](#fig4){ref-type="fig"}, as per reviewers' suggestions) and include details of these analyses in the Methods.

We agree with the Reviewer that the increase in immobile actin is surprising, given the known roles of LIMK1. We have therefore modified both the Results and Discussion to highlight this finding and to include three possible explanations for this result, which we summarize here:

One possible explanation arises from the ability of active (dephospho-) cofilin to induce a twist in actin filament conformation that propagates along the filament (e.g. [@bib5], Trends Cell Biol.). Filaments are more likely to sever at boundaries between cofilin-bound (twisted) and unbound (untwisted) regions ([@bib9], J. Mol. Biol.). However, an entire cofilin-bound filament, as might occur in the absence of LIMK1, is more stable than a bare filament ([@bib18], Biophys Chem; [@bib2], Mol. Cell). Thus, LIMK1 knockdown (and CCSS-LIMK1 'rescue') spines may contain a subset of filaments that are decorated with active cofilin but which are actually more stable.

A second possibility is that LIMK1 knockdown (which is predicted to lead to increased levels of dephospho-cofilin) enhances formation of cofilin-actin rod. Rods are stable structures that are only formed by dephospho-cofilin amd actin turnover within rods is very slow ([@bib7], Am. J. Physiol. Cell Physiol.). However, although this explanation could account for the reduced mobility of GFP-actin that we observe, we note that cofilin-actin rods have been documented in neurites but not, to our knowledge, within spines.

A third, intriguing explanation, which we favor, arises from a prior report that LTD-like stimuli (low frequency electrical stimulation or bath application of NMDA) markedly increase actin filament stability in spines ([@bib62], Nat Neurosci). Strikingly, as noted in our initial manuscript, the LT[P]{.ul}-like stimulus used in our uncaging experiments usually triggers spine enlargement, but in a subset of LIMK1 knockdown and CCSS-LIMK1 rescue spines, instead triggers spine shrinkage ([Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}). This suggests that some LIMK1 knockdown (and CCSS-LIMK1 rescue) spines respond to LTP-like inputs with LTD-like outputs i.e. that their learning rules are impaired. Spontaneous bursts of activity in our cultured neurons may therefore be interpreted as an LTD-like stimulus by some LIMK1 knockdown spines. In the short term this may result in decreased actin filament turnover, as reported by Star et al., while over longer times this impaired actin turnover may contribute to the spine shrinkage and synapse loss seen in the absence of palmitoyl-LIMK1. We note that the three explanations above are not mutually exclusive and could all contribute to the impaired actin filament turnover in the absence of palmitoyl-LIMK1.

*2) Similarly, the FRAP experiments shown in* [*Figure 1--figure supplement 1*](#fig1s1){ref-type="fig"} *provided somewhat surprising results, and should be analyzed and discussed more carefully. Based on these experiments, it seems that both wild-type LIMK1 and CCSS-LIMK1 display very slow dynamics in spines. This indicates that LIMK1 associates in spines with other proteins that severely limit its mobility. To understand the dynamics of wild-type LIMK1 and CCSS-LIMK1 in spines, the authors should perform similar data fitting as requested for GFP-actin above as well as perform FRAP analysis on GFP alone as a control (i.e. to measure the dynamics of a truly soluble protein in spines). Overall, these data seem to suggest that palmitoylation is not required to immobilize LIMK1 in spines, but rather plays a more complex role in localizing this protein to dendritic spines and regulating its activity at these sites*.

This is another insightful point by the Reviewer, which we have also addressed in our reply to the Major Comments. To summarize briefly, we have expanded [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"} to include quantitative measurements of the size of the stable fractions and the dynamics of the mobile fractions, for both wt- and CCSS-LIMK1-GFP. We agree with the reviewer that the slow dynamics of CCSS-LIMK1 recovery suggest that LIMK1 associates with other proteins that limit its diffusion and have modified our Discussion to include this point. In particular, based on the markedly different targeting and phosphorylation of wild type LIMK1, compared to myr-SC and myr-CS LIMK1, we emphasize that palmitoylation is critical for targeting LIMK1 to spines and does not act as a simple membrane anchoring signal.

As mentioned in our reply to the Major Comments, we found that soluble GFP fluorescence recovers too rapidly for us to plot recovery curves under the conditions used for our GFP-actin and LIMK1-GFP experiments. However, we note that several published studies (e.g. [@bib62], Nat Neurosci; Sharma et al., 2006, Mol. Cell. Neurosci; [@bib76], J. Neurosci) have already documented this extremely fast fluorescence recovery for soluble GFP in dendritic spines. We have included this point in our Results section and noted that it supports the reviewer's conclusion that other factors, most likely protein-protein interactions, markedly limit LIMK1 diffusion in spines.

*3) The data presented in* [*Figure 4*](#fig4){ref-type="fig"} *are not particularly convincing and could perhaps be deleted from the manuscript. Is it possible that the differences in LIMK1 and NPY co-localization as well as in LIMK1 targeting to spines after brefeldin A treatment in proximal vs. distal regions could result from differences in the rate of depalmitoylation at these regions (instead of different palmitoyl acyltransferases interacting with LINK1 at different regions of dendrites)*?

We agree with the Reviewer that our conclusions based on the data in [Figure 4](#fig4){ref-type="fig"} were somewhat premature. The possibility that differential thioesterase (as opposed to PAT) activity could explain these results is an insightful observation that we had not considered. As a result we have decided to follow the Reviewer's suggestion to remove [Figure 4](#fig4){ref-type="fig"} and will seek to better define the mechanisms that control LIMK1 palmitoylation in future work.

Reviewer \#2:

*This manuscript by George et al reports the role of LIMK1 palmitoylation in the 1) This study mainly monitors actin polymerization and activity-dependent changes in spine volume as functional measures of the proposed mechanisms. However, actin dynamics and structural plasticity of dendritic spines have been keenly associated with the maintenance and plasticity of* "*functional*" *strength of excitatory synapses. Demonstrating the importance of LIMK1 palmitoylation in the maintenance of excitatory synaptic transmission and glutamate uncaging-induced functional plasticity would much strengthen the manuscript*.

We agree with the reviewer that the possibility that palmitoyl-LIMK1 also controls the functional strength and/or plasticity of excitatory synapses is an exciting one. We therefore performed new experiments to address whether the activity-dependent structural plasticity, which is palmitoyl-LIMK1-dependent ([Figure 5](#fig5){ref-type="fig"}), is accompanied by changes in functional plasticity. In a new [Figure 5--figure supplement 2](#fig5s2){ref-type="fig"} we now include important proof-of-principle experiments that confirm that our 2-photon uncaging stimulation reliably increases not only spine volume but also AMPA uncaging-evoked postsynaptic currents (uEPSCs), and that both changes are specific to the stimulated spine. Importantly, previous studies reported very similar molecular requirements for spine-specific structural and functional plasticity, and in particular identified key roles for actin polymerization and Cdc42 signaling in both processes ([@bib42], Nature; [@bib46], Nature). Our new experiment therefore supports the hypothesis that LIMK1 palmitoylation may also be required for activity-dependent functional plasticity, and may be a key link between the Cdc42 signaling and actin polymerization described by others. We have modified our Discussion to include these important points.

We are interested to further pursue how palmitoyl-LIMK1 might regulate functional plasticity e.g. by affecting different populations of neurotransmitter receptors, but are aware that this question differs from the focus of our current manuscript on spatial control of actin dynamics. We therefore prefer to fully address this issue in future work, and note that in several studies that focused on mechanisms of spine cytoskeletal regulation using 2-photon uncaging (e.g. [@bib11], Neuron; Steiner et al., 2008, Neuron; Tanaka et al., 2008, Science), functional plasticity experiments were limited to confirming that the same uncaging protocol induces both structural and functional plasticity, as we now demonstrate.

*2) It is unclear what lies in the upstream of LIMK1 palmitoylation. Is NMDAR activation required? Is the activation of CaMKII or PAK required for LIMK1 palmitoylation? Which PATs are involved in LIMK1 palmitoylation? Is the T508 phosphorylation of LIMK1 required for its palmitoylation? These aspects are all unclear and should be explored to some extent or, less ideally, discussed. Some questions marks can be added to the summary diagram in Figure 10*.

We appreciate the importance of all of these questions. We previously assessed neuronal LIMK1 palmitoylation levels by ABE assay, but observed no changes following treatment with either Bicuculline or KCl. These results, while preliminary, suggest that LIMK1 palmitoylation is largely constitutive and that other aspects of LIMK1 regulation e.g. its phosphorylation by PAK, which is likely CaMKII-dependent, are more likely to be the key activity-regulated steps in neurons. However, as we detect the entire cellular complement of palmitoyl-LIMK1 in ABE assays, irrespective of subcellular location, it is still possible that synaptic activity or other stimuli alter palmitoylation of a specific subcellular pool of LIMK1. We have added these points to the Discussion.

We also comprehensively assessed, as described in our response to the overall Other Comments, the PATs that can palmitoylate LIMK1 in cotransfected HEK293T cells, but found that several PATs can increase LIMK1 palmitoylation. More work will therefore be required to determine how LIMK1 palmitoylation is controlled in neurons. Again, we have briefly noted these preliminary findings in the Discussion, and are excited to fully address this issue in future studies.

Reviewer \#3:

*Critique: The sound experiments presented and the high quality results shown in the figures require very little comment. However there are some results that are missing which would be welcome additions to what is presented*.

*A question remains as to the role of the dipalmitoylation--- is it simply membrane anchoring or does the membrane insertion of this region alter the interactions with other binding partners of the LIMK1 N-terminus? I am surprised that the authors did not use the N-myr mutant protein with a single cysteine in the palmitoylation region (CS or SC) such that a doubly acylated N-terminal tail (myristate and palmitate) resulted. Would this behave identically to the dipalmitoylated species? Unless the N-terminal myristoylation interfered with recognition of the palmitoylation domain by the PAT, this experiment should be easily done. If the Myr/Palm form is bound to membrane in spines, is it activated normally by signaling through Pak*?

We appreciate the reviewer's interest in the role of the dipalmitoylation of LIMK1 and agree that examining the targeting and regulation of a "myristoyl + palmitoyl" LIMK1 is an excellent way to gain more insight into this issue. We therefore generated both Myr-SC- and Myr-CS-LIMK1 mutants and examined their localization and activation status in neurons. Interestingly, neither mutant recapitulates the spine enrichment or activation status of wild type LIMK1. We have included the additional localization data in a new [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}, modified [Figure 7](#fig7){ref-type="fig"} to include the additional phosphorylation data, and have added an additional statement regarding the unique role of dipalmitoylation to the Discussion. We also include a brief statement that the phosphorylation of Myr-CS-LIMK1 differs from either SC-LIMK1, CS-LIMK1 or myr-CCSS-LIMK1. This result suggests that, at least for Myr-CS-LIMK1, the addition of the myristolyation tag does not interfere with recognition of the remaining palmitoyl-site, but that myristate+palmitate is not equivalent to di-palmitoylation.

*The evidence for the Golgi-dependence for proximal spine delivery of the palmitoylated LIMK1 is very strong, but the evidence for distal spine delivery requiring localized PAT activity is speculative. Although this mechanism is certainly possible, it may not be the only possibility for distal delivery. Until somatodendritic PATs can be down regulated differentially from those at the Golgi, it may remain a speculation*.

We agree with the reviewer that our current evidence is insufficient to conclude that localized PAT activity controls distal spine delivery of palmitoyl-LIMK1. This point was also raised by Reviewer \#1, who suggested that [Figure 4](#fig4){ref-type="fig"} could therefore be removed. We have decided to follow this suggestion and to fully address the control of LIMK1 palmitoylation in future studies.

*In spite of the very high quality work shown in the studies presented here, there are still many unanswered questions regarding the model put forward to explain the centripetal retrograde flow of actin subunits that are adding onto actin filaments at the spine periphery and disassembling in the center. In this regard it is incorrect to talk about cofilin as* "*severing filament pointed ends*" *(in the subsection headed "Polarized "shell-to-core" actin regulation in spines by palmitoyl-LIMK1") and referencing the 2003 Pollard and Borisy review. Severing can occur anywhere in the filament where ADP-actin subunits predominate (which is generally more toward the pointed end of dynamic filaments). However, the type of turnover of these branched networks that is occurring is more correctly termed array treadmilling and there are many more current reviews, one of which should be cited for this. Given that the authors favor a cofilin gradient model, it is surprising that the Discussion fails to include a reference to work published from the Zheng lab in Nature Neuroscience (Gu J, et al., Nat Neurosci 13, 1208-1215, 2010) in which cofilin inhibition by LIMK1 was required for LTP-induced spine enlargement, a role proposed here for the LIMK1 in spines*.

*The speculative model that focuses on the possibility of a cofilin activity gradient also requires some comment. There are many additional factors that need to be considered. First, for cofilin to be regulated in such a manner its concentration would have to be quite low in spines and one would expect the phosphatases, which regulate its activation, would also need to be localized to the central domain because their activity seems to dominate the phosphorylation state of cofilin (see Gu paper referenced above and others). There is evidence that slingshot-1L, a major cofilin phosphatase is only active when bound to F-actin, a fact that could help support the gradient model (Nagata-Ohashi K, et al. J Cell Biol. 165: 465-471, 2004: Soosairajah J, et al., EMBO J 24, 473-486, 2005). However, other studies suggest that the actin filament severing activity of cofilin is modulated (enhanced) in vivo by Aip1 (see recent Chen et al., J Biol Chem, 290: 2289-2300, 2015 and references theirin) and that cofilin\'s recruitment to F-actin is also modulated by coronin 1A (Kueh HY et al., J Cell Biol. 182:341-353, 2008). These proteins likely impact the actin dynamics and retrograde flow. Finally, many (perhaps all?) spines may undergo transient penetration by microtubules (Merriam EB, et al., J Neurosci 33: 16471-82, 2013)), whose assembly may also be modulated in a LIMK1-dependent manner by p25/TPPP, a protein that affects HDAC activity and acetylation of MTs (Acevedo K, et al., Exp Cell Res, 313, 4091-4106, 2007; Schofield AV, et al., J Biol Chem 288: 7907-17, 2013). I am not trying to argue for any one of these models, but simply believe that in this paper the authors have not convinced me that a gradient of cofilin activity exists nor that cofilin is the only target involved in regulating the actin dynamics. Maybe tone this model down a bit and remove the figure since such a figure is often what the reader will take away, even if totally speculative*.

These are all excellent points and we thank the reviewer for this very informative summary of possible alternative explanations and hypotheses. We have markedly modified our Discussion of sub-spine regulation by LIMK1 to reference the supportive studies mentioned by the reviewer, but also to include the alternative/additional explanations that s/he describes. We have taken care to note that our thoughts on intra-spine actin regulation by palmitoyl-LIMK1 are speculative and have modified Figure 10 to remove the cofilin gradient model as suggested.
